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PROLOGUE 
This project was part of a collaboration between France and Mexico that has been 
supported by the ECOS-ANUIES-CONACyT program (project: M02-S01 “Education 
in DNA array technology and practical application in functional genomic in eukaryotic 
cells”). The interest in studying the mechanism related to degenerative diseases is to 
search novel approaches to early detection and treatment of those diseases.  
The aim of this project was to define the gene expression and metabolic changes that 
take place during the oxidative stress-related hepatitis and hepatocarcinogenesis. In 
Toulouse (France) we found both the animal model and the technology to achieve this 
objective. 
The LEC rat model is considered a model of interest, because it is shown to generate 
liver cancer related to inflammation and oxidative stress. LEC rats are bred in the 
Institut National de la Recherche Agronomique (INRA), where the metabolism of lipid 
peroxidation products (reflects of oxidative stress) and their biological importance are 
studied. Using the “omics” technologies, it was possible to evaluate the global mRNA 
expression and metabolic end products. These “omics” technologies, transcriptomics 
and metabonomics, have been successfully developed in the institutions in where the 
project took place: the microarray technology at the Institut National des Science 
Appliquées (INSA), within the Toulouse Genopôle; and the metabonomics at INRA. 
The knowledge and the experience of these groups in biochemical and functional 
genomics areas, allowed me the use of these new approaches to formulate some new 
hypothesis of oxidative stresss-induced hepatitis that could be further analyzed in the 
effort to better understand pathologies as hepatitis and hepatocarcinogenesis. 
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A.1 THE CONCEPT OF OXIDATIVE STRESS 
 
The redox state of a cell is defined by the reduction potential (Eh) of all the redox 
couples present in the cell, and because of its high abundance, glutathione (GSH) 
represents one of the principal molecules that define the cellular redox potential 
(Schafer et al., 2001). The redox environment of the cell can be estimated through the 
redox state of the glutathione couple (GSSG/2GSH). Modifications in the reduction 
potential of the GSSG/2GSH couple have been associated with the biological status of 
the cell, for example, cell proliferation takes place at a Eh ≈ -240mV, differentiation at a 
Eh ≈ -200mV; or apoptosis at a Eh ≈ -170mV (Schafer et al., 2001). These data point out 
the importance of redox balance in biological systems, and is the basis of the oxidative 
stress concept.  
By definition oxidative stress is an increase in the reduction potential or a large decrease 
in the reducing capacity of the cellular redox couples (Genestra, 2007). In other words, 
oxidative stress is the result of an increased oxidized molecule production and a 
diminution of their elimination. One group of these oxidized molecules responsible for 
oxidative stress is the reactive oxygen species (ROS) family. As defined by their name, 
ROS are species of oxygen which are in a more reactive state than molecular oxygen, 
and by which therefore, oxygen is reduced to varying degrees. ROS compile a big 
family of molecules, the most studied in biological systems are described in Table I. 
ROS are produced by all aerobic cells. Under physiological conditions mitochondrial 
production of ROS has been estimated for about ~2% of the total oxygen uptake by the 
organisms (Inoue et al., 2003).  
ROS can be produced by endogenous and exogenous sources (Figure 1). Endogenously, 
ROS arise from mitochondria, cytochrome P450 metabolism, peroxisomes and 
 24 
 
OXIDANT REPRESENTATION CHARACTERISTICS 
Superoxide anion O2
- 
One-electron reduction state of O2. 
Formed in many autoxidation reactions 
and by the electron transport chain. 
Rather unreactive but can release Fe2+ 
from iron-sulphur proteins and ferritin 
Hydrogen peroxide H2O2 
Two-electron reduction state, formed by 
dismutation of O2
- or by direct reduction 
of O2. Lipid soluble and thus able to 
diffuse across membranes. In aqueous 
solution can oxidize or reduce a variety 
of inorganic ions 
Hydroxyl radical OH· 
Three-electron reduction state, formed 
by Fenton reaction and decomposition 
of peroxynitrite. Has a very short in vivo 
half-life of approximately 10-9 s and a 
high reactivity, will attack most cellular 
components. It can damage virtually all 
types of macromolecules: 
carbohydrates, nucleic acids, lipids and 
amino acids 
Organic hydroperoxide ROOH 
Formed by radical reactions with 
cellular components such as lipids and 
nucleobases. Specific functional group 
or a molecule containin and oxygen-
oxygen single bond (R-O-O-R) 
Alkoxy, perory radicals RO·, ROO· 
Oxygen centred organic radicals. Lipid 
forms participate in lipid peroxidation 
reactions. Produced in the presence of 
oxygen by radical addition to double 
bonds or hydrogen abstractions 
Hypochlorite HOCL 
Formed fron H2O2 by myeloperoxidase. 
Lipid soluble and highly reactive. Will 
readily oxidize protein constituents, 
including thiol groups, amino groups 
and methionine. 
Peroxynitrite ONNO- 
Is an oxidant and nitrating agent, 
formed in a rapid reaction betwen ·O2 
and NO·. Lipid soluble and similar in 
reactivity to hypochlorite. Can damage 
a wide array of molecules in cells, 
including DNA and proteins: 
Protonation forms peroxynitrous acid, 
which can undergo homolytic cleavage 
to form hydroxyl radical and nitrogen 
dioxide 
 
 
Table I. Principal ROS studied in biological systems. Adapted from Genestra (2007).  
 
 25 
inflammatory cell activation (Conner et al., 1996; Valko et al., 2006). Xenobiotic 
metabolism, ionizing radiation and cigarette smoking are examples of exogenous 
sources for ROS production. The generation of some ROS is closely linked to cellular 
redox-active metals, like iron and sometimes copper. Iron and copper content in cells is 
a strictly controlled mechanism that ensures that there is no free intracellular iron or 
copper ions. However under some stress conditions, release of copper or ion leads to an 
uncontrolled ROS production (Leonard et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Sources of cell ROS production 
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Due to their high reactivity, ROS can react very quickly between each other and with 
other molecules present in the cells. Interaction of ROS with cellular lipids, proteins and 
nucleic acids are thought to be mechanisms by which oxidative stress modulates cellular 
faith (Droge, 2002). Here I will describe some of the reactions of ROS with 
biomolecules and the consequence of these interactions on cellular damage and 
carcinogenesis. However, our current knowledge of ROS biochemistry show that they 
have not only deleterious effects but they actually can act as second messengers in cell 
signaling (Genestra, 2007).  
 
A.1.1 Oxidative DNA damage 
Among ROS, the hydroxyl radical (OH·) is one of the most reactive. OH· is known to 
react with all components of the DNA molecule, including purine and pyrimidine bases 
and the deoxyribose backbone (Dizdaroglu et al., 2002). Fixation of DNA oxidative 
modifications may be involved in mutagenesis and hence in carcinogenesis. Different 
types of tumor have been shown to present oxidative-related DNA damage. ROS-induce 
DNA damage involves single- or double-stranded DNA breaks, purine and pyrimidine 
oxidation and DNA cross-links. Other oxidative stress DNA-modifications include lipid 
peroxidation-DNA adducts. Consequences of DNA modifications include transcription 
modifications, induction of signal transduction pathways, replication errors and 
genomic instability (Valko et al., 2006). Evidences of DNA-ROS interaction in tumors 
have been demonstrated by measuring the levels of 8-hydroxyguanine (8-OHG) (Floyd, 
1990). 8-OHG is actually considered a potential marker of carcinogenesis (Olinski et 
al., 2003). Both mitochondrial and genomic DNA are susceptible of oxidative-related 
DNA damage, and both are also related to tumor development (Klaunig et al., 2004).  
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Repair mechanisms of DNA modifications are well studied. The major pathway for the 
repair of ROS-induced DNA modifications is considered to be the base excision repair 
(BER) pathway (Cadet et al., 2000). Alterations in BER pathway caused by diet 
modifications, inflammation or other factors are associated to human cancers, as seen by 
a diminution in BER enzymes activities in lung and tobacco-associated cancer patients 
(Tudek et al., 2006; Tudek, 2007), enforcing the importance of ROS-induced DNA 
alterations in cancer development. 
 
A.1.2 Lipid peroxidation 
One of the well recognized targets of oxidative stress are cellular membranes. 
Polyunsaturated fatty acid residues of phospholipids are extremely sensitive to 
oxidation. Lipid peroxidation refers to the oxidative degradation of lipids. It is the 
process by which lipids are attacked by reactive molecules (i.e. ROS) abstracting a 
hydrogen atom from a methylene carbon in their side chain. The overall process of lipid 
peroxidation consists of three stages: initiation, propagation and termination. Lipid 
peroxidation products include alcanes like pentane and ethane (Valko et al., 2006), 
aldehydes like 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA) (Esterbauer et 
al., 1991; Comporti, 1998), and isoprostanes like the 8-IsoPGF2α (8-IsoProstaglandin 
F2α) (Pratico et al., 2004) (Figure 2).  
Both MDA and HNE have the ability to interact with biomolecules as proteins and 
nucleic acids. MDA is mutagenic in bacterial and mammalian cells, it reacts with DNA 
to form the premutagenic pyrimido[1, 2-a]purin-10(3H)-one (M1G) adduct (Plastaras et 
al., 2000). M1G adduct is mutagenic in E. coli, inducing transversions to T and 
transitions to A (Fink et al., 1997). Similarly, HNE is genotoxic for hepatocytes and 
cerebral endothelial cells. Treatment of hepatocytes with HNE leads to a spectrum of 
 28 
 
 
 
Figure 2. Lipid peroxidation process. Figure adapted from Young and McEneny (2001) 
(Young et al., 2001). 
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DNA alterations from sister chromatide exchanges to microsomal aberrations (Eckl, 
2003). HNE is considered as a second messenger of oxidative stress (Zarkovic et al., 
1999; Zarkovic, 2003). Cellular signaling leading to apoptosis, proliferation or 
differentiation can be modulated by HNE depending on its intracellular concentration 
(Yang et al., 2003). HNE has been associated to cancer initiation by direct DNA 
adduction (Hu et al., 2002) and by inhibiting the enzymes related to BER (Feng et al., 
2004). 
 
A.1.3 Protein modification by ROS 
Protein oxidation results from the reaction of ROS with both amino acid side chains and 
peptidic backbone. Oxidative damage to proteins can take place within almost all the 
amino acids, being the most reactive with sulfur amino acid-containing proteins (Berlett 
et al., 1997). Certain oxidations of proteins are reversible, mainly oxidative 
modification of cysteine and methionine can be reversed by enzymatic systems like 
glutaredoxin/glutathione/glutathione reductase systems or thiorredoxin/thioredoxin 
reductase systems (Holmgren et al., 2005). This reversibility of protein oxidation is very 
important in cell signaling pathways and it is considered one of the main mechanisms of 
redox signaling (Droge, 2002). Changes in the local redox state of protein sulfhydryls 
leads to conformational changes that, depending on the protein, can either diminish or 
augment DNA binding activity, or promote protein complex formations which are 
necessary for signal transduction or transcription to proceed (Allen et al., 2000). 
Irreversible oxidized proteins are hydroxylated and carbonylated amino acid derivates. 
These moieties are chemically stable; hence, protein carbonyl groups are used as 
biomarkers of oxidative stress. Accumulation of protein carbonyls has been observed in 
Alzheimer’s disease, diabetes, inflammatory bowel disease, among others (Dalle-Donne 
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et al., 2003). Oxidized proteins are generally less active, and are exposing hydrophobic 
amino acids at their surface, leading to changes in protein conformation and activity 
(Friguet, 2006).  
Elimination of mild oxidized proteins is preferentially done by the 20S proteasome in a 
ATP- and ubiquitin-independent manner (Grune et al., 1995; Grune et al., 2003b). 
However, strong protein oxidation or/and under strong oxidative stress condition lead to 
proteasome inhibition (Grune et al., 1995). Accumulation of damaged proteins due to 
proteasome inhibition has been associated to metabolic perturbations, aging and 
different pathologies including Parkinson and Alzheimer diseases (Hayashi et al., 1998; 
Ciechanover, 2005; Reed et al., 2007), but little is known about proteasome inhibition in 
carcinogenesis. 
 
A.1.4 Cellular adaptive responses to oxidative stress 
Living aerobic organisms have developed elaborate sequences of adaptative 
mechanisms to regulate oxygen homeostasis. The “antioxidant network” as defined by 
Chaudiere et al. includes non-enzymatic and enzymatic antioxidant defenses, cofactors 
and metabolic pathways that act in an orchestrated manner in order to minimize the 
damaging effects of ROS (Chaudiere et al., 1999).  
Non-enzymatic antioxidants include small hydrophobic and hydrophilic molecules. 
They act as chemical traps of oxidizing free radicals and ROS. Hydrophilic scavengers 
are mainly represented by GSH and ascorbic acid, they are found in cytosolic, 
mitochondrial and nuclear aqueous compartments.  Hydrophobic antioxidants are found 
in lipoproteins and cell membranes where they inhibit or interrupt chain reactions of 
lipid peroxidation (Halliwell et al., 1993). They include vitamin E (α-tocopherol), 
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carotenoids and ubiquinol. Essentially, non-enzymatic antioxidants are a first defense 
against free radical formation by quenching nonspecifically free radicals. 
More sophisticate mechanisms for ROS control include enzymatic antioxidants.  
Antioxidant enzymes include superoxide dismutases (SODs), which ensure the 
enzymatic degradation of superoxide ion. Hydroperoxides are degraded by catalase 
(CAT) and glutathione peroxidase (GPX) or ascorbate peroxidase. GPX and ascorbate 
peroxidases are reductases whose reducing coenzymes are regenerated by NADPH 
equivalents produced in metabolic pathways (Chaudiere et al., 1999). Thiol-containing 
proteins such as thioredoxins, thioredoxin reductase, peroxyredoxins and glutaredoxins 
are mainly implicated in reduction of oxidized proteins (Holmgren, 2000). Other 
enzymatic systems are designed for ROS and ROS-oxidized molecules elimination. 
Glutathione S-transferases (GSTs) inactivate endogenous lipid peroxidation products 
(aldehydes such as HNE), quinines, epoxides and hydroperoxides formed as secondary 
metabolites during oxidative stress (Hayes et al., 2005).  
Cellular defense mechanisms of oxidative stress might be activated by cellular sensors 
of oxidative damage. Activation of gene expression in response to oxidative stress is 
related to transcription modulation by transcription factors like NFκB, Nrf2 and AP-1 
(Allen et al., 2000; Scandalios, 2005). Direct signaling of H2O2 in the differential 
regulation of antioxidant genes likely occurs via protein-DNA interactions in the Nrf2-
antioxidant responsive element (ARE) and via NFκB in the promoters of these genes. 
For example, HNE induces thioredoxin system gene expression through Nrf2 signaling 
in neural cells as an adaptive response to mild oxidative stress (Chen et al., 2005; Tanito 
et al., 2007).  
Cellular response face to oxidative stress is complex and depends on levels of ROS 
production. While mild oxidative stress is related to physiological process such as 
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proliferation and differentiation, strong and uncontrolled oxidative stress leads to cell 
death by apoptosis or necrosis (Droge, 2002). Whether ROS effect on cells is beneficial 
or pathological depends on complex factors that are not fully understood. Nevertheless, 
the role of free radicals, mainly ROS, in pathophysiology is evident. The aim of this 
work is to focus on ROS-induced hepatitis as a model for ROS modulation of cell faith 
in relation to hepatocarcinogenesis.  
 
A.2. OXIDATIVE STRESS AND LIVER DISEASES 
In humans, chronic liver diseases are generated by different causes. Chronic alcohol 
consumption, viral infections, metabolic dysfunctions, xenobiotic exposition and metal 
overload are factors associated with hepatitis and liver tumor development. Oxidative 
stress seems to be a common mechanism involved in all these different hepatitis causes 
(Vendemiale et al., 2001; Nagasaka et al., 2006; Seitz et al., 2006). Patients suffering 
from hepatitis C manifest hepatic oxidative stress, condition that is exacerbated by 
alcohol consumption (Wang et al., 2006). 8-Nitroguanine, a marker of DNA oxidation, 
is highly formed in patients with hepatitis C. Furthermore, some hepatitis C virus 
(HCV) carriers with normal alanine aminotransferase (ALT) levels in serum have 
elevated levels of lipid peroxidation products and low levels of reduced glutathione 
(GSH) in plasma. In these patients, a greater degree of oxidative stress markers 
correlates with a more severe status of the disease (Vendemiale et al., 2001).   
 
A.2.1 Wilson’s disease 
Wilson’s disease is an autosomal recessive disorder of copper transport. Affected 
individuals exhibit excessive copper accumulation in the liver and brain, deficient 
holoceruloplasmin biosynthesis and a marked impairment in biliary copper excretion 
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(Linder et al., 1996). The gene defective in Wilson’s disease is the ATP7B gene which 
encodes a P-type ATPase, the Wilson protein (WND) (Tanzi et al., 1993). WND is 
responsible for copper transport from the cytoplasm to the trans-golgy network, where 
copper is bounded to apo-ceruloplasmin to be excreted into plasma (Pfeil et al., 1999). 
Mutations in WND results in misdistribution of the protein and in a defective 
intracellular copper transport. As a consequence copper accumulates in cells, generating 
ROS production and hence oxidative stress. Wilson’s disease patients suffer of recurrent 
or fatal hepatitis and of neurological disorders. Wilson’s disease patients die either due 
to progressive liver failure or neurological deterioration. Hepatocelullar carcinoma 
(HCC) is a rare condition in Wilson’s disease, but some cases have been reported 
(Iwadate et al., 2004). The low incidence of HCC in patients with Wilson’s disease may 
be attributable to the significantly shortened life in untreated patients that does not allow 
time for cancer to develop (Pfeil et al., 1999).  
 
A.2.2 Hepatocarcinogenesis 
Liver carcinogenesis is associated with chronic inflammation and cirrhosis. Persistent 
infection with HCV is a major risk factor for development of HCC. Mechanisms 
associated to HCV-related HCC include mitochondrial oxidative stress and metabolic 
alterations in lipid and glucose metabolism together with continued cell death and 
regeneration associated with inflammation (Koike, 2007). In alcohol-related 
hepatocarcinogenesis, oxidative stress generated from alcohol metabolism, 
inflammation, and increased iron storage are important mechanisms (Seitz et al., 2006).  
Carcinogenesis is a complex multistage process in which both proliferation and cell 
death are altered. According to observations made in models of chemical carcinogenesis 
(mainly in liver) and in epidemiological findings, the process of neoplastic development 
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has been operationally divided into three defined stages: initiation, promotion and 
progression (Farber et al., 1986; Trueba et al., 2004; Anisimov, 2007). Initiation follows 
irreversible changes in the genotype of cells (i.e. mutations in critical genes such as 
oncogenes and tumor suppressor genes). The promotion stage is characterized by the 
clonal expansion of initiated cells by the induction of cell proliferation and/or inhibition 
of cell death. This process results in the formation of identifiable focal lesions 
(preneoplastic lesions). Progression involves cellular and molecular changes that occur 
from the preoneoplastic to the neoplastic state. This stage is mainly characterized by 
genetic instability and disruption of chromosome integrity (Klaunig et al., 2004).  
During the first stages of carcinogenesis, cells acquire a resistant phenotype, by which 
cells are resistant to physiological mechanism of cell growth regulation and also to 
cytotoxic environments (Laconi et al., 2000). Hence, initiated cells might be more able 
to proliferate and resist to apoptotic physiological stimulus. Such phenotype is seen in 
cancer cells, and it is explained by overexpression of genes related to toxic metabolite 
excretion like multi-drug resistant protein (MDR), GSTs and GSH-associated enzymes 
(Tew, 1994). Liver carcinogenesis is a good example of the phenotypic resistance in the 
pathogenesis of neoplasia hypothesis. During initiation, hepatocytes acquire the 
expression of proteins related to GSH metabolism. Moreover two of these proteins, the 
glutathione-s-transferase type pi (GSTP) and the γ-glutamyltraspeptidase GGT, are 
actually considered as early tumor markers (Pitot et al., 1996).  
Initiation stage of liver carcinogenesis is closely related to liver injury and consequent 
cellular turnover caused by the different etiologies of hepatitis (McGlynn et al., 2005; 
El-Serag et al., 2007). Mechanisms by which hepatocytes are transformed into 
preneoplastic and neoplastic cells are not well understood, but the influence of ROS and 
oxidative stress in this process becomes more evident. Because of the complexity of 
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carcinogenesis, it is difficult to explore the mechanisms of ROS-related 
hepatocarcinogenesis in a gene by gene or isolated pathway matter, and a global 
analysis of cellular and liver behavior under oxidative stress is necessary.   
 
A.3 OMICS TECHNOLOGIES AND SYSTEMS BIOLOGY 
A.3.1 Omics approaches, what do they mean? 
From many years science used “reductionism” as tool to explain global phenomena. 
Reductionism refers to the attempt of explaining complex phenomena by studying 
functional proprieties of the individual components that compose a multicomponent 
system (Strange, 2005). Even if these kind of studies remains and will remain essential 
for biological understanding of specific situations in a phenomenon, they are not longer 
effective in explaining the whole phenomena. Thanks to advances in biotechnology, 
analytical chemistry and bioinformatics it is now possible to study, in a large scale, the 
principal components of a biological system (Ivakhno, 2007). Genomics is defined as 
the study of genes and their products in an organism as a whole. Functional genomics 
goals include the integral study of the molecules that form part of the biological 
systems, i.e. RNA, proteins and metabolites and which interactions and function lead 
life to cells (Hocquette, 2005; Strange, 2005).   
In order to understand functional genomics some definitions are necessary:  
Genome: The complete collection of hereditary information of an individual organism. 
This includes both genes and non-coding sequences of the DNA. 
Transcriptome: Set of all messenger RNA (mRNA) molecules or transcripts produced 
in one or a population of cells. It reflects the genes that are being actively expressed at 
any given time. 
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Proteome: The entire complement of proteins expressed by a genome, cell, tissue or 
organism. Specifically this term has been used to define the whole expressed proteins at 
a given time point under defined conditions. 
Metabolome: Complete set of small-molecule metabolites to be found within a 
biological sample. 
The global study of each of these fields has lead to new disciplines in biology: 
Transcriptomics, proteomics and metabonomics for the study of the transcriptome, the 
proteome and the metabolome, respectively (Hocquette, 2005). Together this new 
approaches allow the description and comprehension of complex cellular networks in 
which communication between genes, proteins and physiological adaptation through 
metabolic profile changes are taken in account (Ivakhno et al., 2007). Omic approaches 
are promising in understanding disease mechanisms and in the research of new early 
markers for the detection of diseases.  
 
A.3.2 Transcriptomics 
The study of transcriptomics examines the expression level of mRNAs in a given cell 
population, often using high-throughput techniques including differential display, serial 
analysis of gene expression (SAGE) and cDNA or oligonucleotid arrays (Chittur, 2004). 
The principle of arrays is simple: thousands of probes (DNA fragments corresponding 
to different genes) are immobilized on a solid support (nylon membranes or glass slides) 
and a specific labeled target made from RNA isolated from the sample of interest is 
hybridized with the probes. The signal intensity of each individual probe should 
correlate with the abundance of the mRNA complementary to that particular probe 
(Brentani et al., 2005). 
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DNA microarrays have been used for the study of several pathologies. In the liver, the 
principal objectives imply the research for markers that would allow early diagnosis of 
diseases like cirrhosis or HCC to proceed (Chen et al., 2003; Nakatsura et al., 2003). 
Using DNA microarrays coupled to unsupervised hierarchical clustering, Lee et al. 
classified patients suffering of HCC, their results showed the power of transcriptomic 
analyses in tumor classification and prognosis (Lee et al., 2004). Similarly, Perez-
Carreon et al. described a list of differential expressed genes implicated in experimental 
chemical hepatocarcinogenesis (Perez-Carreon et al., 2006).  
 
A.3.3 Proteomics 
The main objective of proteomics is to quantify protein levels and their dynamic 
changes. Proteins are mainly studied by physical separation using two-dimensional (2D) 
electrophoresis. The resulting gel contains the proteome separated by the 
physicochemical properties of proteins, molecular weight and isoelectric point. Most 
current studies in proteomics are based on mass spectrometry to detect and identify 
proteins (Spahn et al., 2004). Applications of proteomics for the discovery of 
serological tumor markers for clinical use are promising (Poon et al., 2001). More 
interestingly, using this kind of analyses, researches have been able to define set of 
proteins sensitive to oxidative modifications caused by ischemia/reperfusion damage 
(Cesaratto et al., 2005).  
Methodological limitations such as difficulties with membrane-associated, very acidic 
or very basic, very low or very high molecular weight and very low abundance proteins 
are still causing difficulties in proteome study (Humphery-Smith, 2004); nevertheless, 
technical improvements are promising (Bunai et al., 2005).  
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A.3.4 Metabonomics 
The analysis of the final metabolic products is possible grace to high-output analytical 
techniques like 1H nuclear magnetic resonance (1H NMR) and mass spectrometry (MS). 
These technologies have lead to the characterization of metabolic modifications caused 
by different stimulus such as drug treatment, diseases or xenobiotic exposition (Griffin, 
2003). Metabonomics is defined as “the quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to pathophysiological stimuli or 
genetic modification" (Nicholson et al., 2002). The objective of metabonomics is to 
study all metabolites present in a biological system without any bias associated with the 
choice of the metabolites to be studied. This helps the identification of metabolic 
networks (Lindon et al., 2005; Teahan et al., 2006). One advantage of metabonomics is 
the possibility of studying the effects on general metabolism by analyzing urine or 
serum samples. This would make possible to follow the time-related metabolic 
responses under specific conditions. This is a revolutionizing approach for clinical and 
pharmacological applications (Fan et al., 2004).  
Metabonomics has been used in the investigation of drug-induced hepatotoxicity, and it 
is nowadays considered as a useful tool in pre-clinical and clinical studies in drug 
development (Kleno et al., 2004; Mortishire-Smith et al., 2004). In an integrative 
clinical approach, using transcriptomic and metabonomic analyses, factors involved in 
bad prognosis of neuroendocrine cancers have been described (Fan et al., 2004; Ippolito 
et al., 2005).  
 
A.3.5 Systems biology: Integrating the puzzle 
The function of living organisms cannot be addressed satisfactorily by looking at 
molecules alone. Classical isolated molecule studies are very useful to explain how 
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molecules work, but are very poor in information of how molecules interact in complex, 
multicomponent biological processes.  
Systems biology is an emerging field of biological science. Its goal is to understand the 
integrated function of the different parts of an organism in order to identify molecular 
interaction networks on the basis of correlated molecular behavior observed in omic 
studies (Strange, 2005). In order to achieve this ambitious aim, it is necessary to link 
quantitative data from omic approaches with phenotypic observations. One of the 
challenges of omic experiments is how to detect meaningful patterns in the massive 
amounts of data generated and how to deduce experimentally testable functions from 
those patterns. 
Bioinformatics is a tool for biologists useful to aboard this problem; it merges biology 
with dedicated statistics methods and databases to develop algorithms and statistical 
methods necessary to access, manage and analyze large data sets and assess their 
interrelationships (Werner, 2007).  In order to better explore omic data, multivariate 
statistical analyses have been successfully used (Perez-Enciso et al., 2003). It is out of 
scope in this work to deep into the mathematical bases of multivariate statistical 
analyses; a basic explanation of the methods used in this thesis is given in when used in 
chapter D.2. 
The integrative system approaches have great advantages. One is to bring the research 
into a new vision of without an a priori formulation of hypothesis. In the past, 
hypothesis-driven research was conducted with the aim of testing biological hypothesis 
which emerged from previous studies or theoretical considerations. Nowadays, with 
omic technologies, new hypothesis are generated with the scope of the key role of some 
unknown molecules (Dmitrovsky, 2004). The idea is to search molecular signatures 
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(cluster of genes, of proteins, of metabolites, etc) which would characterize a biological 
process or a specific phenotype.   
 
A.4 THE LEC RAT MODEL 
The general aim of this work was to define in an integrative approach the gene 
expression and metabolic changes during the onset of oxidative stress-induced 
hepatocarcinogenesis. In order to achieve this objective we chose Long Evans 
Cinnamon-like color (LEC) rats as model.  
LEC rats generate spontaneous acute hepatitis, fibrosis and liver tumors as a 
consequence of an abnormal liver copper (Cu) accumulation and subsequent oxidative 
stress (Mori et al., 1994). This rat strain shows chronic liver damage, hepatocyte death 
and regeneration, at the promotion stage of carcinogenesis. Such a natural history of 
HCC development in LEC rats is similar to that of human HCC. 
 
A.4.1 Copper accumulation in LEC rats 
LEC rat is an inbred strain of a mutant rat that was originally isolated from a closed 
colony of Long Evans rats. LEC rats are characterized by excessive Cu accumulation in 
the liver and impaired biliary Cu excretion (Li et al., 1991). Cu accumulation produces 
great quantities of ROS, mainly the hydroxyl radical (OH·), which is believed to be the 
origin of the acute hepatitis and the subsequent HCC that is observed in this rat strain 
(Yamamoto et al., 2001). 
LEC rats have a deletion in the gene homologous to the Wilson’s disease gene, the 
ATP7B gene (Yamaguchi et al., 1994). Wu et al. identified the LEC Atp7b gene 
mutation. The disease causing mutation is a deletion of 900 bp in the 3’ terminus which 
removes the critical ATP binding domain of the wild type gene leading to a non 
functional protein (Wu et al., 1994). Introduction of human ATP7B gene into LEC rats 
 41 
restores biliary Cu excretion and prevents hepatic abnormalities, showing that Atp7b 
gene mutation is solely responsible for LEC rat pathologies (Meng et al., 2004). 
Hepatocyte Cu distribution in LEC rats progresses from being initially well distributed 
in cytoplasm, bound to metallothionein (Cu-Mt complexes) to an accumulation of the 
Cu-Mt complexes in the lysosome just before acute hepatitis. The acid conditions in the 
lysosome result in the degradation of these complexes resulting in the formation of a 
partially polymerized Cu-Mt containing reactive copper (Klein et al., 1998). This Cu 
initiates lysosomal lipid peroxidation, leading to hepatocyte necrosis and fulminant 
hepatitis. 
 
A.4.2 Clinicopathological characteristics of LEC rats 
LEC rats present elevated hepatic Cu levels, reduced biliary Cu excretion, haemolysis, 
ceruloplasmin deficiency and increased hepatic iron levels. This mutant strain also 
possesses reduced hepatic selenium that may induce a reduction in the antioxidant 
capacity against copper induced free-radical damage (Downey et al., 1998).  
Around 11-16 weeks old LEC rats suffer from an acute hepatitis period, with symptoms 
of jaundice. Kasai et al. have described the clinicopathological characteristics of the 
acute hepatitis in the LEC rat (Kasai et al., 1990). Around one week from the first 
hepatitis sign, LEC rats suffer from a fulminant hepatitis period in which 40-50% of rats 
die. The remaining animals can survive for more than 1 year with chronic hepatitis and 
develop preneoplastic and neoplastic lesions of the liver such as hepatocellular 
carcinoma (HCC) together with cholangiofibrosis (Figure 3). Most of the liver cancers 
are histologically classified as well-differentiated HCC. Sex differences exist in 
hepatitis index and liver tumor formation. Male LEC rats have more HCC formation
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Figure 3. Clinico-pathological description of LEC rat spontaneous hepatitis and hepatocarcinogenesis. Photo: LEC rat (Cinnamon-like color 
rat) and Long Evans (LE) rat (Black and white color rat). Scheme adapted from Masuda, et. al. 1988 (Masuda et al., 1988).  
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frequency while females develop cholangiocarcinoma more frequently. Moreover, 
hepatitis in female LEC rats takes place earlier than in males (Kasai et al., 1990). 
The study of liver lesion incidence shows a sequential development of liver foci, 
nodules and HCC similar to those seen in chemical hepatocarcinogenesis models. 
Furthermore, the phenotype of preneoplastic and neoplastic lesions in LEC rat is the 
same as in chemical hepatocarcinogenesis, with increased levels of the positive tumor 
markers GSTP, GGT and α-fetoprotein (AFP) and decreased levels of the negative 
markers glucose-6-phosphatase (G6Pase) and adenosine triphosphatase (ATPase) 
(Sawaki et al., 1990).  
 
A.4.3 Mechanism of hepatocarcinogenesis in LEC rats 
Hepatocarcinogenesis in LEC rats is related to liver Cu and iron accumulation, since in 
rats fed a low Cu and iron diet or treated with copper-chelating agents, preneoplastic 
lesions almost disappear (Jong-Hon et al., 1993; Hayashi et al., 2004). Copper-
associated liver injury is regarded as resulting ultimately from oxidative stress. OH· 
production in rats suffering from hepatitis is increased compared with Wistar rats and 
LEC rats showing no signs of hepatitis (Yamaguchi et al., 1994). When LEC rats were 
treated with the OH· scavenger D-mannitol, a decrease in ALT and bilirubin 
concentrations together with a reduction in mitochondrial lipid peroxidation was 
observed.  
Lipid peroxidation products like HNE and MDA may be implicated in 
hepatocarcinogenesis initiation in LEC rats. Increased mutagenic exocyclic DNA 
adducts were observed in the liver of LEC rats. These adducts come from the addition 
of lipid peroxidation products to DNA (Nair et al., 1996). Levels of etheno-DNA 
adducts, 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine, increase with age 
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reaching a peak at 8 and 12 weeks in nuclear and mithochondrial DNA, respectively 
(Nair et al., 2005). Acute hepatitis in LEC rats impairs the repair of oxidative DNA base 
damage by altering the expression of DNA glycosylases, endonuclease II and 8-
oxoguanine DNA-glycosylase which initiate the BER pathway  (Choudhury et al., 
2003).  
During hepatitis, p53 expression and hepatocyte apoptosis are higher in LEC rats than 
in age matched control rats (Jia et al., 2002). Although p53 expression is increased, Ba 
et al., using a yeast-based functional assay, demonstrated the presence of p53 mRNA 
mutations in LEC rat liver. The authors suggest that during hepatitis, the cellular 
damage degrades transcriptional fidelity and that mutations in p53 may have an effect in 
p53 function and hence in cell cycle control (Ba et al., 2000).  During chronic hepatitis, 
there is a continuous cellular turnover. However the proliferation/apoptotic index ratio 
indicates an imbalance in favor of cellular proliferation (Jia et al., 2002). The analysis of 
G1 phase-related cell cycle cyclines suggest that while cycline D1 may be involved in 
the regeneration of hepatocytes during chronic hepatitis, cyclin dependent kinase 4 
(Cdk4) may play an important role in the development of HCC since it is significantly 
increased in HCC compared to precancerous and chronic hepatitis LEC rat livers (Kita 
et al., 2004). Together theses results indicate that during HCC development in LEC rats, 
there is an increase in hepatocyte proliferation rather than a diminution in apoptosis, as 
is the case in human HCC. 
LEC rat is accepted as good model for Wilson’s disease. Several studies using different 
compounds have been made in order to test their efficiency in diminishing hepatic 
failure and HCC development. Cu-chelating agents like D-penicillamine, trientine 
dihydrochloride and N-benzyl-D-glucamine dithiocarbamate show good results in 
inhibiting hepatitis and HCC formation by preventing the Cu-dependent ROS 
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production in LEC rats (Jong-Hon et al., 1993; Hayashi et al., 2004; Shimada et al., 
2005). D-penicillamine is one of the treatments of choice for Wilson’s disease patients. 
D-penicillamine not only prevents the development of hepatitis, but it can reverse the 
hepatitis evolution by dissolving the polymerized Cu-Mt complexes and diminishing 
ROS production (Klein et al., 2000). Antioxidant treatment has successfully diminished 
the incidence of hepatic failure in LEC rats. N-acetylcysteine (Kitamura et al., 2005), 
proline, ascorbic acid, thioredoxin in combined administration have significantly 
delayed the appearance of jaundice and rat mortality (Hawkins et al., 1995).  
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B. AIMS OF THE STUDY 
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The interest of studying the hepatitis process using global approaches comes from the 
idea to evaluate the changing phenotype that leads to hepatitis and cancer initiation 
without any bias that could be produced by pre-formulated hypothesis. This would 
allow us to search for new markers for early detection and treatment of hepatitis and to 
increase the knowledge of oxidative stress-related mechanisms of disease and cell 
regulation. 
The general aim of this work was to define the oxidative stress-induced gene 
expression and metabolic changes during the hepatitis development and the onset 
of the hepatocarcinogenesis process. 
In order to achieve this objective we have chosen the LEC rat model, in which ROS 
induction is closely related to hepatitis and hepatocarcinogenesis development. As 
hepatitis in this rat strain is spontaneous, its development is not synchronic. The first 
goal of the project was then to define some biochemical parameters in order to get a 
good classification of rats according to their hepatitis state and their degree of 
oxidative stress.  
Hepatocarcinogenesis in LEC rats has been well studied and it has been established as a 
multistep process that follows an initiation-promotion-progression development of 
preneoplastic and neoplastic lesions. Hepatocyte initiation is thought to take place 
during hepatitis, but there are no clear results of it and some controversial data point out  
hepatocyte initiation before hepatitis development as shown by increased levels of 
tumor marker expression in hepatocytes in LEC rats without hepatitis. In order to define 
the period of hepatocytes initiation we aimed to explore the tumor marker expression 
in different LEC rat groups before and during hepatitis development. 
The election of a suitable control group to compare both ROS-induced gene expression 
and metabolic perturbations that lead to hepatitis and cancer initiation was a critical 
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stage in this work. We explored the use known preventive strategies to obtain a group of 
rats that behave as normal rats without oxidative stress or hepatitis induction. To 
validate D-penicillamine treated LEC rats as a suitable control group for 
transcriptomic and metabonomic approaches, we evaluated the biochemical and 
histological parameters of hepatitis development in these rats and we compared them 
against non diseased LEC rats and Long Evans (LE) rats.  
Transcriptomic changes in LEC rats towards hepatitis were defined using DNA 
microarray approaches comparing those LEC rats at different hepatitis stages against the 
control group of D-penicillamine-treated LEC rats. In order to explore the high amount 
of data coming from transcriptomic data, multivariate statistical analyses were 
performed.  To define those changes in gene expression that might have an impact 
in the development of hepatitis we used pattern recognition methods that allowed us to 
discriminate between non diseased and diseased animals and to correlate the known 
biochemical markers of hepatitis. Those selected genes would be useful for making 
some new hypotheses concerning ROS-induced cell damage and cancer induction. 
Changes in gene expression can lead to metabolic perturbations by changing enzyme 
cell content. Moreover, ROS can directly modulate general metabolism by altering 
enzyme and protein function. We were then interested in studying the metabolic end 
product changes in a global context using metabonomic approaches. The evaluation 
of small molecules in urine that might be related to hepatitis development may lead to 
the identification of new markers for early detection that could be analyzed in a non 
invasive way. On the other hand, the evaluation of changes in liver metabolome could 
be useful for studying the mechanism of ROS-induced inflammation and cancer 
initiation.  
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Systems biology refers to the integration of omic data in the objective of better 
understanding the global function of cells and organisms. In an effort of better 
understanding hepatitis and cancer processes, we aimed to integrate the data coming 
from transcriptomic analyses to those coming from metabonomics. The correlated data 
would be useful to define some of the cellular networks associated to ROS-induced liver 
damage. 
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C. MATERIAL AND METHODS 
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 C.1 ANIMALS AND TREATMENTS 
 
Long Evans Cinnamon-like (LEC) rats were bred in our Institution animal facility from 
rats kindly given by Dr. Matsumoto from Tokushima University (Japan). Male LEC rats 
were maintained in metabolic cages from 6 weeks old until sacrifice at different 
hepatitis stages. Male 5 weeks old Long Evans rats were purchased from Janvier (Le 
Genest-Saint-Isle, France) and maintained for acclimatizing for 1 week before the 
beginning of experiments at 6 weeks old. Untreated Long Evans rats were sacrified at 
13 weeks old. For D-penicillamine-treated rats group, 6 LEC and 6 Long Evans rats 
were administered with D-penicillamine in drinking water (100 mg/kg/day) for 6 weeks 
until sacrifice at 13 weeks old. D-penicillamine (Sigma, Saint-Quentin Fallavier, 
France) concentration was adjusted every three days according to water consumption.  
 
C.2 URINE COLLECTION AND STORING 
Urine samples were collected daily from rats housed in plastic metabolic cages. 0.5 ml 
of a 360 mM butylhydroxytoluene (BHT) ethanolic solution was added to the urine 
collection tubes that were placed in a unit maintained at 0 ºC during urine collection. 
24-h collected urine samples were stored at -20 ºC until analysis. 
 
C.3 TISSUE PREPARATION 
Rats were sacrified by exsanguination under ether anesthesia. Blood was taken from the 
aorta vein for plasma separation. Liver was excised, washed in physiological saline 
solution. For RNA isolation, liver samples were immersed in RNAlater (Qiagen, 
Courtaboeuf, France) following manufacturer’s instructions and stored at -80 ºC. For 
histological examination, liver samples were fixed in 4% buffered formaldehyde, 
embedded in paraffin. For GGT activity histochemistry, liver fractions were frozen by 
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immersion in liquid nitrogen-cooled 2-methylbutane and stored at -80 ºC. The rest of 
liver samples were immediately frozen in liquid nitrogen and stored at -80 ºC. 
 
C.4 HEPATITIS MARKERS IN PLASMA DETERMINATION 
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) activities and total 
bilirubin (t-bil) levels in plasma were determined by the Toulouse Genopôle, 
“Exploration physiopathologique”. 
 
C.5 OXIDATIVE STRESS DETERMINATION 
C.5.1 8-Isoprostaglandine F2α (8-IsoPGF2α) urine determination by Enzymatic 
Immunoassay (EIA) 
This assay is based on the competition between 8-IsoPGF2α and 8-IsoPGF2α-
acetylcholinesterase (AChE) conjugate (8-IsoPGF2α tracer) for a limited number of 8-
IsoPGF2α-specific rabbit antiserum binding sites (Pradelles et al., 1985; Wang et al., 
1995). Because the concentration of the 8-IsoPGF2α tracer is held constant while the 
concentration of 8-IsoPGF2α varies, the amount of 8-IsoPGF2α tracer that is able to bind 
to the rabbit antiserum will be inversely proportional to the concentration of 8-IsoPGF2α 
in the sample. This rabbit antiserum-8-IsoPGF2α (either free or tracer) complex binds to 
the anti-rabbit IgG mouse monoclonal antibody that is attached to the well. A 
calibration curve from 7.2 pg/ml to 1 ng/ml is used. Samples were assayed in duplicates 
with a 1:20 dilution. After an incubation period of 18 h with the specific antibody, tracer 
is added for another incubation period during 4 h. Then, the plate is washed to remove 
any unbound reagent and Ellman’s Reagent (which contains the AChE substrate) is 
added to the well. The product of this enzymatic reaction is determined 
spectrophotometrically at 414nm using a plate reader (Multiskan Ascent, Thermo 
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Labsystem, Cergy Pontoise, France). The color intensity is proportional to the amount 
of 8-IsoPGF2α tracer bound to the well, which is inversely proportional to the amount of 
free 8-IsoPGF2α present in the well during the incubation. All results were expressed on 
the basis of 24 h excretion.  
 
C.5.2 1,4-dihydroxynonane-mercapturic acid (DHN-MA) urine determination by 
Enzymatic Immunoassay (EIA) 
This competitive immunoenzymatic assay follows the same principle of that of the 8-
IsoPGF2α described above. EIA analyses were performed according to Gueraud et al 
(Gueraud et al., 2006). Urine samples were assayed in duplicates with a 1:200 dilution. 
A calibration curve was performed with a standard solution (32 pg/ml to 10 ng/ml of 
DHN-MA). After an incubation period of 18 h at 4ºC with the specific antibody and 
tracer, the plate was washed and the tracer fraction bound to the antibody was reacted 
with Ellman’s reagent, which is the acetylcholinesterase enzyme substrate (tracer). The 
resultant colored reaction was read at 414 nm using a plate reader (Multiskan Ascent), 
color development being inversely proportional to the concentration of DHN-MA 
measured. All results were expressed on the basis of 24 h excretion. 
 
C.6 HISTOLOGY ANALYSES 
C.6.1 Hematoxylin and eosin staining 
5 µm liver sections were obtained from formalin-fixed paraffin samples with a 
microtome, and sections were attached to silane-coated microscope slides. Slides were 
deparaffinized and rehydrated as follows: two incubations of 5 minutes in xylene 
followed by two incubations of 4 minutes in 100% ethanol, one incubation of 4 minutes 
in 96% ethanol and one incubation of 4 minutes in 70% ethanol. Slides were then 
 58 
washed in double distilled water. Sections were then stained with Mayer’s hematoxylin 
for 6-10 seconds and immediately washed with tap water. Then slides were immersed in 
acid ethanol (1% HCl and 70% Ethanol) for 2 minutes and then washed with tap water. 
Subsequently, slides were stained with eosin for 1-3 minutes and then washed in 
distilled water. After staining, slides are dehydrated and mounted with Canada balsam.  
 
C.6.2 Immunohistochemistry of Glutathione S-transferase, placental form (GSTP) 
Deparaffinized sections were blocked for 1 hour in 0.1% H2O2 in phosphate-buffered 
saline (PBS), pH 7.4. Subsequently, they were incubated with commercial monoclonal 
antibodies specific to glutathione S-transferase, placental form (GSTP, 
DakoCytomation, Glostrup, Denmark) diluted 50 times in blocking buffer overnight. 
After washing with PBS, the primary antibody was detected using an avidin-biotin 
complex immunoperoxidase technique (Zymed Laboratories, Inc., Carlsbad, CA). 
Slides were counterstained with hematoxyline and observed in light microscopy. 
 
C.6.3 Immunohistochemistry of 4-hydroxynonenal (HNE) 
In order to diminish the in situ formation of HNE, slides were incubated with H2O2 as 
substrate for peroxidase only after antibodies attachment. Hence, deparaffinized 
sections were incubated in methanol for two minutes then they were washed in PBS 
three times of five minutes each. Subsequently, slides were incubated overnight with 
monoclonal antibodies specific to HNE-histidine adducts diluted (1:5) in 1% bovine 
serum albumin diluted in PBS. After washing with PBS, slides were incubated with 3% 
H2O2 in PBS for 15 minutes in the dark. Then, slides were washed in TBS three times 
for 5 minutes. Subsequently the primary antibody was detected using a Dako LSBA2 
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avidin-biotin complex immunoperoxidase system (DakoCytomation). Slides were 
counterstained with hematoxyline and observed with a light microscopy.  
 
C.6.4 Histological detection of gamma-glutamyl transpeptidase (GGT) positive 
hepatocytes 
GGT activity can be detected in frozen liver histological sections according to 
Rutenburg et al. (Rutenburg et al., 1969). Representative 5 µm thick sections from 2-
methylbutane-protected frozen liver slices were obtained with a cryostat at -15ºC. Slides 
were fixed in 96% ethanol for 5 minutes at -20ºC. Slides were then incubated for 20 
minutes at room temperature in a reaction buffer containing 125 µg/ml gamma-
glutamyl-1-4-methoxy-2-nafthylamide (GMNA), 0.5 mg/ml glycil-glycine and 0.5 
mg/ml fast-blue in 100 mM Tris pH 7.5.  A red precipitate is then formed in GGT 
positive cells. Slides were then rinsed with distilled water and incubated in 0.1M cupric 
sulfate for 5 minutes at room temperature. Finally, slides were rinsed with distilled 
water and dried. Slides were counterstained with hematoxyline and observed with a 
light microscopy. 
 
C.7 PROTEASOME PEPTIDASE ACTIVITIES 
C.7.1 Cytosol extraction 
10% (w/v) liver homogenates were prepared in 50 mM Tris-HCl pH 8.0 containing 0.1 
mM EDTA and 1 mM β-mercaptoethanol. Homogenates were centrifuged at 100,000 g 
for 1 h at 4 ºC; supernatants were stored at -80 ºC until use. 
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C.7.2 Proteasome activity assay 
Chymotrypsin-like (ChT), trypsin-like (TL) and peptidylglutamyl peptide hydrolase 
(PGPH) proteasome activities were determined with fluorogenic synthetic peptides N-
Succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (LLVY-AMC), BOC-Leu-Ser-
Thr-Arg-7-amido-4-methylcoumarin (BOC-AMC) and Z-Leu-Leu-Glu-β-
naphthylamide (Z-LLG-NA), respectively. Assays were performed as described by 
Fataccioli et al. (Fataccioli et al., 1999). Briefly, cytosolic fractions containing 150 µg 
of protein were incubated with fluorogenic substrates (50 mM) and SDS 0.06 % in 150 
mM Tris-HCl pH 8.0 for 30 minutes at 37 ºC. The reaction was stopped by adding 1 ml 
SDS 1% and 2 ml 0.1 M sodium borate pH 9.1. The peptidase activity was determined 
fluorometrically by measuring the release of 7-amino-4-methylcoumarin (λexc = 370 nm, 
λem = 430 nm) and 2-naphthylamine (λexc = 323nm, λem = 400 nm) in a Jobin Yvon 
spectrofluo JY3D fluorometer (Horiba Jobin Yvon, Longjumeau, France). A standard 
curve of fluorescence for 7-amino-4-methylcoumarine and 2-naphthylamine was used to 
calculate the concentration of liberated products in the assay. 
 
C.8 SDS-PAGE AND IMMUNOBLOTTING 
Cytosolic protein fractions were separated by SDS-PAGE using a mini-PROTEAN II 
electrophoresis cell (Bio-Rad, Marnes la Coquette, France). Following transfer, the 
nitrocellulose membranes were probed with antibodies to proteasome C2 subunit, 
PROS-30 (Santa Cruz Biotechnology, Inc., Tebu-Bio, Le Perray en Yvelines, France), 
or α-Tubulin (Clone B-5-12) (Sigma) diluted 1:300 and 1:1000 respectively. Antibodies 
were visualized using the ECL chemiluminescent system from Amersham Biosciences 
(GE Healthcare, Ramonville Saint-Agne, France).  
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C.9 RNA EXTRACTION 
Total RNA extraction from RNAlater-stabilized liver samples was performed following 
the instructions from Qiagen RNeasy mini kit using the On-Column DNase digestion 
set (Qiagen, Courtaboeuf, France). Quality and quantity were determined by capillary 
electrophoresis on the bioanalyzer from Agilent (RNA 6000 Nano Assay, Agilent, 
Massy, France) and by spectrometric analysis on a NanoDrop ND-1000 
spectrophotometer (Nyxor Biotech, Labtech, Palaiseau, France). Only samples with λ260 
nm/λ280 nm ratio above 1.9 and rRNA28S/ rRNA18S ratio above 1.7 were taken for DNA 
microarray and quantitative RT-PCR assays. 
 
C.10 QUANTITATIVE RT-PCR (QRT-PCR) 
2 µg of total RNA were reverse transcribed using SuperScript II-reverse transcriptase 
system (Invitrogen, Cergy Pontoise, France) following manufacturer’s instructions. 
Quantitative PCR assay for cDNA was carried out using TaqMan Universal PCR master 
mix in a AB PRISM 7000 sequence detection system (Applied Biosystem, Courtaboeuf, 
France). The fluorescent probe for rat glutathione S-transferase pi (GSTP) gene, probe 
code: Rn00821792_g1, was used. Data were normalized against beta actin gene 
expression, probe Rn00667869-m1 (Applied Biosystem). Signals were quantified using 
a standard curve made by serial dilutions of a cDNA pool from all samples. 
 
C.11 MICROARRAY ANALYSIS 
C.11.1 DNA microarray slides 
DNA microarray glass slides were made at Biochips Platform of Toulouse Genopôle 
(Toulouse, France). Rat 70mer oligos from Operon_V3_rat oligo set (Operon 
Biotechnologies, Cologne, Germany) were loaded at 300 pmol/well. Oligos were 
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resuspended in 20 µl 3× SSC buffer (final concentration 20 µM). Spotting was 
performed as single spot per probe on Ultra GAPS glass slides (Corning, Fontainebleau, 
France) using Genetix Qarray mini robot (TeleChem International Inc., Saint Marcel, 
France). Atmosphere moisture was set at 50% and plates were cooled to 15 ºC to 
prevent drying. Spotting design was as follows: 48 grids, each grid containing 24×25 
spots. Each slide bears 28000 spots corresponding to 27004 transcripts and 22012 rat 
genes. 
 
C.11.2 Preparation of labeled cDNA 
Total RNA (5 µg) was used for cDNA preparation. Reverse transcription was made 
using ChipShotTM reverse transcriptase from Promega (Promega, Charbonnieres Les 
Bains, France) using Cy3- and Cy5-dCTP from Amersham Bioscience. cDNA 
purification was made by the Promega ChipShotTM labeling Clean-up system. Dye 
incorporation was checked by measuring the absorbance at 260 and 550 nm for Cy3 and 
260 and 650 nm for Cy5 in a NanoDrop spectrophotometer (Nyxor Biotech). 
 
C.11.3 Array hybridization and scanning 
Equal amounts of Cy3- and Cy5-labeled cDNA from control and tested groups were 
hybridized for 8 hours at 42ºC in the automatic Hybridization Machine Discovery from 
Ventana (Ventana Medical Systems, Illkirch, France). After hybridization, slides were 
washed twice in 2× SCC (Ribowash buffer, Ventana Medical Systems) for 5 minutes 
with agitation and then once with 0.1× SSC buffer. After washing, slides were dried by 
centrifugation. Slides were scanned with Axon 4000A Microarray Scanner (Molecular 
Devices, Saint-Grégoire, France). 
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C.11.4 Data analysis and public access 
All data reported here are available to public, via NCBI-GEO platform, as both original 
and normalized data. Image analysis was made by Genepix Pro V6 software. Each spot 
was evaluated and selected to be analyzed by Bioplot software (http://biopuce.insa-
toulouse.fr). Spot analysis consisted in background subtraction with Lowess allowed 
value 10, log transformation and Lowess normalization. The generated data set has been 
submitted to the National Center for Biotechnology Information (NCBI) Gene 
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/projects/geo/) database 
(GSE7654). 
Data analysis consisted of a variance analysis. The whole data set (27004 gene probes) 
was subjected to an ANOVA using SPLUS 2000 software (MathSoft Inc., Seattle, WA). 
Significance was set as P-value < 0.05. Partial Least Square (PLS)-2, PLS-Discriminant 
Analysis (PLS-DA) and orthogonal signal correction (OSC) were made using SIMCA-P 
8.0 software (Umetrics, Umea, Sweden). Oligos that contribute to axis building for both 
PLS-2 and PLS-DA analyses were defined by the Variable Importance Projection (VIP) 
criterion given by the SIMCA-P 8.0 software.  
For biological organization of data, gene ontology (GO) classification was performed 
by Gene Ontology Tree Machine from Vanderbilt University 
(http://bioinfo.vanderbilt.edu/gotm) (Zhang et al., 2004). 
 
C.12. METABONOMIC ANALYSES 
C.12.1 Samples preparation for 
1
H NMR spectroscopy 
Urine samples for NMR spectroscopy were prepared by mixing 500 µl of urine with 
200 µl of phosphate buffer in D2O (pH 7.4) containing 10 mM deuterated 
trimethylsilylpropionate as chemical shift reference (δ 0.0). The buffered urine samples 
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were then centrifuged at 10000 rpm for 10 min to remove any precipitates, and aliquots 
of the resulting supernatant (600 µl) were placed in 5 mm NMR tubes. 
Samples of liver tissue (~100 mg) were homogenized in 2 ml of 50/50 acetonitrile/H2O 
containing 0.1% of BHT in an ice/water bath. The homogenates were centrifuged at 
5000 g for 10 min at 4°C. The supernatants were removed and freeze dried before being 
reconstituted in 1 ml D2O. 2 ml of 75/25 chloroform/methanol was added to the pellets 
and extraction was followed by a subsequent centrifugation (5000 g for 15 min at 4°C). 
The lipophilic supernatants were removed, dried under a stream of nitrogen and 
reconstituted in 600 ml of CDCl3. The reconstitued solutions were transferred to 5 mm 
(o.d.) NMR tubes. 
 
C.12.2 NMR spectroscopic analysis  
All 1H NMR spectra were obtained on a Bruker DRX-600 Avance NMR spectrometer 
(Rheinstetten, Germany) operating at 600.13 MHz for 1H resonance frequency using an 
inverse detection 5 mm 1H-13C-15N cryoprobe attached to a CryoPlatform (the 
preamplifier cooling unit). 
1H experiments of urine samples were recorded using the « Improved Watergate » 
sequence for the suppression of the water resonance, accumulating 128 FIDs into 32 K 
data points on a 12 ppm spectral width. All free induction decays were multiplied by an 
exponential function equivalent to a 0.3 Hz line-broadening factor before Fourier 
transformation. 
The 1H NMR spectra of liver extracts were acquired at 300 K using a 1D single pulse, 
accumulating 128 FIDs into 32 K data points on a 12 ppm spectral width. All free 
induction decays were multiplied by an exponential function equivalent to a 0.3 Hz line-
broadening factor before Fourier transformation. 
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600 MHz 1H-1H correlation spectroscopy (COSY) NMR was performed on two aqueous 
extracts samples to confirm the 1H NMR assignments. Transients were acquired into 
1024 data points with 32 scans per increment, a spectral width of 7183 Hz, and 256 
increments in the F1 axis, which was zero-filled to 512 prior to Fourier Transformation. 
The relaxation delay between successive pulse cycles was 1.5 s. The data sets were 
weighted using a sine-bell function in t1 and t2 prior to Fourier Transformation. 
 
C.12.3 Spectra analysis 
All NMR spectra were data-reduced using AMIX (version 3.1, Bruker Analytik, 
Rheinstetten, Germany) to integrated regions 0.04 ppm wide corresponding to the 
region δ 10.0 to 0.5. The regions δ 6.5-4.5 in the urine spectra and δ 5.0-4.7 in the 
aqueous extracts were set to zero integral value to remove the variability of water 
resonance suppression and cross-relaxation effects on the urea signal. For the lipophilic 
extracts, the regions δ 7.5-6.8 (chloroform) and δ 3.6-3.3 (methanol) were removed 
from all spectra. 
Each integrated region (bucket) was considered as a variable for multivariate statistical 
analyses.  
 
C.13 STATISTICAL ANALYSES 
Multivariate statistical analyses are described above. Univariate statistical analysis for 
data from qRT-PCR, proteasome activities and immunoblotting are expressed as means 
and standard deviations. Statistical differences were determined by ANOVA, followed 
by Bonferroni’s post-hoc test. 
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D.1.1 INTRODUCTION AND AIMS 
In order to achieve a better understanding of the role of oxidative stress in cancer, 
suitable models in which direct association between both phenomena could be 
demonstrated are necessary. In this context, LEC rat model for spontaneous hepatitis 
and hepatocarcinogenesis is of interest (Mori et al., 1994).  
This first step in our work aimed to define the biochemical and histological features in 
LEC rat model in order to achieve a good classification of rats that allowed us to 
describe the hepatitis process and at the same time to validate the group of D-
penicillamine treated rats as a control group for further studies in global approaches. 
LEC rats are known to develop liver tumors. Carcinogenesis initiation stage in LEC rats 
is thought to be at the onset of hepatitis, nevertheless, there is some controversial data 
that suggest the acute hepatitis as a promoter stimulus for the cancer process. This 
would mean that before the acute hepatitis, some already initiated cells might be present 
and that during hepatitis those cells will be promoted with the hepatitis-regeneration 
stimulus. In order to define the LEC rat cancer initation stage, we analyzed the tumor 
marker expression in the liver of each LEC rat group. 
 
D.1.2 EXPERIMENTAL PROTOCOL 
D.1.2.1 Hepatitis determination: 
 Plasma ALT and AST activity determination by automated biochemistry 
 Liver structure analysis by H & E staining 
D.1.2.2 Oxidative stress parameters 
 Determination of lipid peroxidation metabolites in urine 
  8-IsoPGF2α by EIA 
  DHN-MA by EIA 
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A. Hematoxylin and Eosin (H & E) staining of liver slides 
 
B. Biochemical features and group classification  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Histological and biochemical features of LEC rats at different hepatitis stages: Rats were classified according to their disease state, 
age and treatment. Values refer to means (SD= Standard Deviation). Means without a common letter differ as determined by ANOVA and the 
Bonferroni post-hoc test 
 Normal 6w Normal 9w Slight jaundice Jaundice F3,20 P  
Age (weeks) 6 9 11-13 11-13 - - 
ALT  (U/l) 62.83(SD 13.7)a 66.7 (SD 7.7)a 584.8 (SD 120.4)b 1184 (SD 344.7)c 50.94 < 0.0001 
AST (U/l) 123.8 (SD 15.3)a 95.5 (SD 7.4)a 479 (SD 144.7)b 725.7 (SD 208)b 33.94 < 0.0001 
T-bilirubin 
(µmol/l) 
2.1 (SD 1.8)a 1.9 (SD 0.8)a 107 (SD 64.7)a 369.7 (SD 228)b 12.87 < 0.0001 
Liver histology Normal Normal 
architecture, 
Slight hydropic 
change. 
Abnormal. Conserved liver 
architecture; cholestasis; 
presence of micronecrosis and 
apoptosis; inflammatory 
infiltrates. 
Abnormal. Necrosis, 
apoptosis, inflammation, 
cholestasis, nuclear 
polymorphism, fat droplets. 
- - 
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Determination of HNE-modified proteins by immunohistochemistry using the 
monoclonal antibody anti HNE-His 
D.1.2.3 Tumor marker expression 
 Determination of GGT activity in liver sections 
 Determination of GSTP protein by immunohistochemistry 
 
 
D.1.3 RESULTS 
 
D.1.3.1 Hepatitits development in LEC rats. 
LEC rats were sacrified at different hepatitis stages, from normal to strong hepatitis 
stage. This rat strain suffers of a period of acute hepatitis between 11-13 weeks with 
symptoms of jaundice. Clinical symptoms of hepatitis included decrease in body 
weight, yellowish skin on ears, tail and feet. During this period, activities of plasma 
enzymes, alanine aminotransferase (ALT), aspartate aminotransferase (AST), as well as 
total bilirubin levels, were significantly increased (Figure 4B). Contrary to “normal” 
groups in which liver architecture was conserved (Figure 4), liver structure was strongly 
altered during hepatitis periods with presence of cholestasis, apoptosis and 
inflammation for the slight jaundice group and strong inflammation, hepatocytes 
nuclear polymorphism and flat droplets (steatosis) in jaundice group.  
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Figure 5. Tumor marker expression in liver of LEC rats at different hepatitis stages: Liver sections were used to detect gamma 
glutamyltranspeptidase (GGT) activity by histochemistry (HC) or glutathione S-transferase, placental type (GSTP) by immunohistochemistry 
(IH) at different hepatitis stages. 
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D.1.3.2 GGT and GSTP expression in hepatocytes of LEC rats 
Glutathione S-transferase (GSTP) and γ-glutamyltranspeptidase (GGT) are two well 
known tumor markers in liver. In order to know in which moment cancer initiation stage 
takes place in LEC rats, we analyzed those tumor marker expression in the liver of LEC 
rats in each hepatitis period. Figure 5 shows histological determination of GGT activity 
and GSTP protein presence in liver sections of LEC rats at different hepatitis stages. 
GGT showed a time-dependent increase, which correlated to the state of disease. GGT 
expression in Normal 6w and Normal 9w rat groups was confined to cells around bile 
caniliculi. As hepatitis developed, GGT activity was detected in almost all hepatocytes 
with no specific topographical distribution. 
The evaluation of GSTP protein in hepatocytes by immunohistochemistry showed that 
GSTP positive hepatocytes appear at the beginning of hepatitis process. Interestingly, 
GSTP was present not only in the cytoplasm but also in the nuclei of hepatocytes in 
Slight jaundice group. This GSTP presence in nucleus is transitory, since in Jaundice 
group, GSTP is present only in the cytoplasm of hepatocytes groups presumed as 
“initiated” cells. These results indicated that the cancer initiation stage takes place just 
before the acute hepatitis.  
 
D.1.3.3 Oxidative stress induction in LEC rats 
Copper-associated liver injury is regarded as resulting ultimately from oxidative stress. 
The majority of the OH· in vivo comes from the Fenton reaction Mn+ + H2O2  M
(n+1)+ 
+ OH· + OH-. The formation of OH· has been demonstrated to initiate the oxidative 
degradation of lipids known as lipid peroxidation.  4-hydroxy-2-nonenal (HNE) is one 
of the major products during lipid peroxidation. HNE is a reactive molecule that can
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Figure 6. HNE-protein adduction in LEC rat liver at different hepatitis stages: 
Immunohistochemistry for HNE-histidine adducts in liver sections of LEC rats at 
different hepatitis stages: A. Normal 6w, B. Normal 9w, C. Slight jaundice, D. Jaundice. 
 
interact with biomolecules as DNA and proteins. HNE-protein adducts were visualized 
by immunohistochemistry (Figure 6). HNE-positive hepatocytes were evaluated in each 
group of rats, rats from the group Normal 6w presented HNE positivity in hepatocytes 
around central vein or in the stroma. Just before the hepatitis in Normal 9w group, HNE 
positivity was diffuse, not intensive but in a lot of hepatocytes. Positivity was both 
cytoplasmic and nuclear or perinuclear, and in some cases nuclear or perinuclear 
positivity was stronger than the cytoplasmic one. In diseased rat groups HNE-modified 
proteins were also present. In Slight jaundice group, HNE positivity is mostly 
cytoplasmic and sporadically positive picnotic nuclei were present. During the acute 
phase of hepatitis, in Jaundice group, HNE positivity was diffuse in hepatocyte 
cytoplasm without any topographic distribution, some apoptotic cells were also positive. 
The main urinary metabolite of HNE in rat is the 1,4-dihydroxynone-mercapturic acid 
(DHN-MA) (Alary et al., 1995; Alary et al., 1998). DHN-MA was assessed as a good 
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marker of HNE formation under oxidative stress conditions (Peiro et al., 2005). We 
have measured DHN-MA in the urine of rat at the day of sacrifice (Figure 7-B). As 
expected, DHN-MA urinary excretion increased 3.6 times in the Slight jaundice group 
compared to the Normal 6w group of rats. However, levels of DHN-MA drastically 
diminished in Jaundice group of rats, even when HNE was constantly produced in liver 
as seen in the HNE-his adducts immunohistochemistry. DHN-MA is formed by the 
metabolism of HNE originated from both cellular oxidative stress and from exogenous 
sources like diet. During the acute phase of hepatitis, rat food consumption drops down 
(Figure 8), so HNE coming from diet might also decrease and consequently levels of 
DHN-MA. Accordingly to this hypothesis, a positive correlation between DHN-MA 
levels and diet consumption was found (Figure 9).  These results showed that DHN-MA 
 
 
 
Figure 7. Lipid peroxidation products’ excretion in urine of LEC rats at different 
hepatitis stages: Urine samples were collected from LEC rats. 8-IsoPGF2α and DHN-
MA were measured by competitive enzymatic immunoassay (EIA). Values refer to 
means and standard deviations. Means without a common letter differ as determined by 
ANOVA and the Bonferroni post-hoc test  
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Figure 8. Diet consumption at different stages of hepatitis in LEC rats. 24 hours diet 
consumption was measured the day of rat sacrifice. Values refer to MEANS and 
Standard Deviation. Means without a common letter differ as determined by ANOVA 
and the Bonferroni post-hoc test. 
 
 
 
 
 
Figure 9. Effect of diet consumption on lipid peroxidation products urinary 
excretion: Correlation between diet consumption and 8-IsoPGF2α or DHN-MA urine 
excretion in LEC rats.  
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levels are very sensitive to exogenous HNE and then it was not a suitable marker for 
endogenous oxidative stress when food consumption is not controlled. 
Isoprostanes are other products of lipid peroxidation. Among them, 8-IsoPGF2α has 
been described as a good marker of oxidative stress and inflammation. 8-IsoPGF2α 
determination in urine showed an increase as hepatitis developed (Figure 7A). Levels of 
8-IsoPGF2α were 6.5 times higher in Jaundice group as compared to Normal 6w group. 
In Figure 9 we show the relation between 8-IsoPGF2α, DHN-MA and diet consumption. 
When rats bear a normal food consumption, corresponding  to non-acute disease, levels 
of 8-IsoPGF2α were low, while as rats stopped eating, levels of 8-IsoPGF2α were high 
because of hepatic inflammation.The contrary is seen with DHN- MA excretion because 
of the decrease of food originating HNE consumption. These observations allowed us to 
consider 8-IsoPGF2α determination as a better marker of lipid peroxidation in situations 
of acute endogenous oxidative stress processes as in the case of LEC rats.  
 
D.1.3.4 Effect of D-penicillamine on hepatitis development 
Figure 10 shows the effect of D-penicillamine administration on hepatitis development 
in LEC rats. As indicated by hepatitis markers on plasma, D-penicillamine stopped 
hepatitis development in LEC rats (Figure 10B). D-penicillamine treatment lead to rats 
with normal liver architecture, low levels of GGT activity and no presence of GSTP in 
hepatocytes (Figure 10A). HNE-modified proteins were only seen around portal veins, 
and urinary levels of 8-IsoPGF2α were diminished by 7.9 times in D-penicillamine 
group of rats compared to non treated rats suffering from hepatitis. 
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A. Histological comparisons between un-treated jaundice LEC rats and D-penicillamine-treated rats 
 
B. Effect of D-penicillamine on plasma hepatitis markers and urinary 8-IsoPGF2α 
Group Jaundice D-penicillamine P 
Age (weeks) 11/13 13 - 
ALT (U/l) 1184 (SD 344.7) 45.7 (SD 2.7) 0.00047 
AST (U/l) 725.7 (SD 208) 81.8 (SD 2.4) 0.00063 
T-bilirrubin (µmol/l) 369.7 (SD 228) 2.3 (SD 0.6) 0.01092 
Liver histology Abnormal. Necrosis, apoptosis, 
inflammation, cholestasis, nuclear 
polymorphism, fat droplets 
Normal. Slight hydropic change - 
8-IsoPGF2α (ng/24h) 50.98 (SD 21.24) 6.43 (SD 1.84) 0.00050 
Figure 10. Effect of D-penicillamine on hepatitis development, carcinogenesis initiation and oxidative stress in LEC rats: Values refer 
MEANS (SD = Standard Deviation), P = p value obtained by two-tailed student t test. 
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D.1.3.5 Comparison between D-penicillamine-treated rats and normal rats 
In order to establish if D-penicillamine-treated LEC rats are a suitable control group for 
further comparisons in global approaches (transcriptomics and metabonomics), we 
compared these rats with the Normal 6w LEC group and a group of Long Evans rats 
which are normal rats. Figure 11 shows the histological and biochemical comparison 
between these groups. In all groups normal liver architecture, negative immunological 
staining of GSTP and HNE-protein adducts were seen (Figure 11A). Plasma levels of 
classical hepatitis markers were also low in all groups (Figure 11B). Together all these 
results allowed us to choose D-penicillamine-treated rats as suitable control group in 
further experiments since they behave as normal rats. 
 
D.1.4 DISCUSSION 
This first part of our study aimed to characterize hepatitis development in LEC rats on 
the basis of observations of jaundice, biochemical parameters of hepatitis, and changes 
in liver histology and to correlate the hepatitis process to oxidative stress and cancer 
initiation processes. Since hepatitis was spontaneous, it differs from each rat and its 
apparition was not synchronic, so rat classification was made according to different 
hepatitis markers (hepatic enzymes and bilirubin in plasma and histological features), 
rather than to a time concerning classification. We were able to classify LEC rats in 4 
groups according to hepatitis stage: Normal 6w, Normal 9w, Slight jaundice and 
Jaundice in which we observed significant differences between groups concerning 
histological features, oxidative stress and tumor marker expression. 
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A. Histological comparisons between LEC rats 6w, D-penicillamine groups and Long 
Evans 
 
B. Plasma hepatitis markers 
GROUP ALT (U/l) AST (U/L) T-BILIRUBIN 
(µMOL/L)) 
Normal 6w 62.83 (SD 13.7)a 123.8 (SD 15.3)a 2.1 (SD 1.8) 
LEC 
D-penicillamine 
45.7 (SD 2.7)b 84.8 (SD 2.4)b 2.3 (SD 0.6) 
Long Evans 28.17 (SD 2.14)c 55.5 (SD 3.57)c 2.06 (SD 1.74) 
F2,15 22.74 56.28 0.2052 
P < 0.0001 < 0.0001 0.8167 
 
Figure 11. Histological and biochemical parameters comparison between LEC rats 
groups (Normal 6w and D-penicillamine) and Long Evans rats. Values refer MEANS 
(SD = Standard Deviation). Means without a common letter differ as determined by 
ANOVA and the Bonferroni post-hoc test. 
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Kasai et al. have described the clinicopathological characteristics of the acute hepatitis 
in LEC rats (Kasai et al., 1990). Similarly to their observations, we have showed that 
the onset of the acute phase of hepatitis was characterized by an increase of apoptosis, 
large nuclei and hepatocytes in mitosis, and that in the fulminant hepatitis period, liver 
necrosis and inflammation were found together with an elevation of plasma enzyme 
activities like ALT, AST and symptoms of jaundice.  
LEC rats have been described to spontaneously develop liver tumors. Tumor formation 
in this rat strain follows a natural history similar to those seen in chemical 
carcinogenesis in which initiation, promotion and progression stages are followed by 
the differential expression of proteins, known as tumor markers, in preneoplastic and 
neoplastic lesions (Sawaki et al., 1990). Two of these known tumor markers are GGT 
and GSTP. Our results showed that both proteins are expressed in hepatocytes at early 
stages of hepatitis. GGT is an ectoenzyme that is expressed in fetal liver and in bile 
canaliculi cells; in the adult rat liver, GGT is normally expressed only in the bile 
canaliculi cells an in the canaliculi membrane face of hepatocytes. GGT activity was 
detected in higher levels in Normal 6w rats than in Normal 9w group, even when 
topographic expression of GGT was normal in both groups. This transitional increase of 
GGT expression was first described by Jain et al. (Jain et al., 1992). They showed an 
increase of GGT mRNA in 4 weeks aged LEC rats that was then diminished in 8 weeks 
aged LEC rats. Moreover, GGT expression was higher in LEC rats than in Long Evans 
Agouti (LEA) rats. The overexpression of GGT in hepatocytes has been associated with 
stress conditions, such as oxidative stress (Yamada et al., 2006) and hepatitis (Paolicchi 
et al., 2005), so the increase seen in the liver of Slight jaundice and Jaundice rat groups 
might correspond to the liver disease state, and because of no specific topographical 
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distribution of GGT activity, it is not possible to associate GGT expression to the cancer 
initiation stage.  
GSTP is considered as one of the most reliable tumor markers in liver (Aliya et al., 
2003). GSTP is normally not expressed in adult rat hepatocytes and it is expressed in 
almost 100% of HCC cells independently of the initiation-promotion stimulus. GSTP 
expression in hepatocytes at early stages of hepatitis enforces the idea of initiation of 
carcinogenesis at these stages. GSTs are mainly expressed in the cytoplasm, and their  
involvement  in  xenobiotic biotransformation, drug metabolism and thiol homeostasis 
has been well documented (Seidegard et al., 1997; Tew, 2007). GSTP is nowadays 
considered as important in tumorigenesis and in cancer drug resistance (Tew, 2007). 
GSTP has been shown to be induced as a cellular response to HNE and its expression 
and activity is closely related to oxidative stress modulation (Fukuda et al., 1997). The 
fact that we have found GSTP expression in nuclei of hepatocytes in early stages of 
hepatitis (Slight jaundice group) remarks the importance of oxidative stress in cancer 
initiation, since nuclear localization of GSTP has been associated with prevention of 
apoptosis during oxidative stress conditions by conjugating lipid peroxidation products 
as 4-oxo-2-nonenal with GSH and by consequence diminishing the formation of 
exocyclic DNA products (Kamada et al., 2004). This suggests the induction of GSTP as 
an adaptive response to oxidative stress. Further investigations may be done in order to 
clarify the importance of this transitional expression of GSTP in hepatocyte nucleus and 
its relation with liver cancer initiation.  
Oxidative stress was clearly related to hepatitis development as demonstrated both by 
increased levels of 8-IsoPG2α in urine and, directly in liver, by formation of HNE- 
protein adducts. HNE is considered as the major lipid peroxidation product that has 
been shown to have not only deleterious effects but also an important role in
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physiological processes as a second messenger of oxidative stress. Its presence is used 
as a marker of oxidative stress in different tissues and cells during pathophysiological 
processes (Zarkovic, 2003). HNE-modified proteins were visualized from young LEC 
rats without signs of hepatitis (Normal 9w rat group). Modification of proteins by HNE 
may be implicated in oxidative stress-mediated carcinogenesis, since it has been 
demonstrated that HNE can inhibit some DNA damage repairing enzymes contributing 
to DNA mutations and genome instability (Feng et al., 2004). HNE positivity was not 
only in cytoplasm but also around the nuclei. This is the first report showing HNE-
modified proteins around hepatocyte nucleus. This interesting finding opens the door to 
new insights of the HNE role in cellular homeostasis and carcinogenesis beyond to the 
already known DNA-HNE adducts. 
One of the aims of this first step of our work was to define a suitable control group of 
rats that would be compared as normal rats in further experiments.  LEA rat strain, 
which is an Atp7b non mutant Long Evans deriving strain, is often used as control in 
LEC rat studies, both rat strains deriving from a common ancestor (Long Evans rats). 
However, LEA rats may have slightly evolved differently from LEC rats as indicated by 
differences in epoxide hydrolase, GGT and UDP-glucoronyltransferase enzyme 
activities and in cytochrome P-450 content between LE and LEA rats (Sugiyama et al., 
1988). Here we have used D-penicillamine in order to inhibit hepatitis development. 
Histological and clinical features of these rats showed that they behave as normal rats, 
according to the known effect of D-penicillamine to inhibit hepatitis and 
hepatocarcinogenesis in LEC rats (Togashi et al., 1992; Klein et al., 2000). 
Furthermore, we compared the histological features and the plasma levels of ALT, AST 
and t-bilirrubin of D-penicillamine-treated LEC rats to those of untreated 6 weeks old 
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LEC rats and to 13 weeks old Long Evans rats. D-penicillamine-treated LEC rats 
behaved as normal rats with normal liver histology and negative staining for GSTP and 
HNE-protein adducts, as well as low levels of hepatitis markers in plasma. Even when 
we found significantly difference between LE and D-penicillamine-treated rats in ALT 
and AST levels, D-penicillamine-treated LEC rats have the same genetic background as 
untreated LEC rats, they were considered as a suitable control for studying the 
mechanisms involved in hepatitis and cancer initiation in LEC rats by transcriptomics 
and metabonomics analyses.  
As a conclusion, in this first stage of our work we defined the rat groups that were then 
used in transcriptomic and metabonomic analyses. Four groups of untreated LEC rats 
were defined: Two non-diseased groups (Normal 6w and Normal 9w) and two groups of 
diseased animals showing different hepatitis stages (Slight jaundice and Jaundice). 
Together these groups of rats allow us to study the hepatitis development and the cancer 
initiation stage in LEC rats, in comparison to a control group formed of D-
penicillamine-treated rats that were shown to behave as normal rats with no hepatitis 
symptoms and no oxidative stress induction. 
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 88 
 89 
D.2.1 INTRODUCTION AND AIMS 
 
Nowadays DNA-microarray technology is a powerful tool to determine the repertoire of 
genes that are differentially expressed in cells or tissues exposed to different stimuli like 
xenobiotic exposure or disease development. Microarray studies have produced detailed 
pictures of gene expression in a sample, information that is not apparent in conventional 
studies. The data sets are large and encompass new described genes. The problem is to 
find relationships or discriminate which expression changes are important in such an 
important mass of data. In these regard, multivariate statistical methods are of interest. 
Biological information from transcriptomic data sets can be captured by correlating 
them with other significant biological information using dedicated statistical methods. 
In this part of our work, we have used Partial Least Squares (PLS) regression and PLS-
Discriminant Analysis (PLS-DA) to select genes that correlated to hepatitis symptoms 
and that discriminated LEC rats at different hepatitis stages, respectively.  
 
D.2.2 EXPERIMENTAL PROTOCOL 
D.2.2.1 cDNA microarray analysis 
 D.2.2.1a RNA extraction 
 D.2.2.1b Preparation of labeled cDNA 
 D.2.2.1c Hybridization array: In Table I the hybridization design is shown. In 
order to diminish the dye bias, caused by unequal amount of dye incorporation, the 
array hybridization followed the dye swap design. Within the same group, three 
independent samples were labeled with Cy3-dCTP and the other three were labeled with 
Cy5-dCTP.
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  Comparison     
Group TEST CONTROL Image file name Chosen chanel 
  Ra0502 Ra0703 05-02Cy3-07-03Cy5 PMT550.grp green 
Normal Ra0602 Ra0803 06-02Cy5-08-03Cy3 PMT550.grp red 
6w Ra0702 Ra0903 07-02Cy3-09.03Cy3 PMT550.grp green 
  Ra2906 Ra1003 29-06Cy5-10-03Cy3 PMT600.grp red 
  Ra3006 Ra1103 30-06Cy3-11-03Cy5 PMT550.grp green 
  Ra3106 Ra1203 31-06Cy5-12-03Cy3 PMT550.grp red 
  Ra0101 Ra1203 01-01Cy3-12-03Cy5 PMT520.grp green 
Normal Ra0201 Ra1103 02-01Cy5-11-03Cy3 PMT520.grp red 
9w Ra2406 Ra1003 24-06Cy3-10-03Cy5 PMT520.grp green 
 Ra2506 Ra0903 25-06Cy5-09-03Cy3 PMT550.grp red 
  Ra3207 Ra0803 32-07Cy3-08-03Cy5 PMT520.grp green 
  Ra3407 Ra0703 34-07Cy5-07-03Cy3 PMT520.grp red 
  Ra0401 Ra0703 04Cy5 07Cy3 680b.grp red 
Slight Ra0601 Ra0903 06Cy5 09Cy3 700b.grp red 
Jaundice Ra1603 Ra0803 16-03Cy3-08-03Cy5 PMT500.grp green 
  Ra2106 Ra1003 21-06Cy3-10-03Cy5 PMT500.grp green 
  Ra2306 Ra1103 23-06Cy5-11-03Cy3 PMT500.grp red 
  Ra1303 Ra1203 13-03Cy3-12-03Cy5 PMT500.grp green 
  Ra0501 Ra0803 08Cy5 05Cy3 650.grp red 
Jaundice Ra1503 Ra1103 15Cy5 11Cy3 650.grp red 
  Ra1403 Ra1003 10Cy5 14Cy3 700.grp green 
  Ra1703 Ra1203 12Cy5 17Cy3 650.grp green 
  Ra2606 Ra0903 26-06Cy3-09-03Cy5 PMT520.grp green 
  Ra2706 Ra0703 27-06Cy5-07-03Cy3 PMT520.grp red 
  Ra0105 Ra0703 01-05Cy3-07-03Cy5 PMT500.grp green 
Long Evans Ra0205 Ra0803 02-05Cy5-08-03Cy3 PMT520.grp red 
  Ra0305 Ra0903 03-05Cy3-09-03Cy5 PMT520.grp green 
  Ra0405 Ra1003 04-05Cy5-10-03Cy3 PMT500.grp red 
  Ra0505 Ra1103 05-05Cy3-11-03Cy5 PMT500.grp green 
  Ra0605 Ra1203 06-05Cy5-12-03Cy3 PMT550.grp red 
  Ra0705 Ra1203 07-05Cy3-12-03Cy5 PMT520.grp green 
Long Evans Ra0805 Ra1103 08-05Cy5-11-03Cy3 PMT520.grp red 
D- Ra0905 Ra1003 09-05Cy3-10-03Cy5 PMT520.grp green 
 penicillamine Ra1005 Ra0903 10-05Cy5-09-03Cy3 PMT520.grp red 
  Ra1105 Ra0803 11-05Cy3-08-03Cy5 PMT520.grp green 
  Ra1205 Ra0703 12-05Cy5-07-03Cy3 PMT520.grp red 
Table II. Array hybridization design: Control group refers to D-penicillamine-treated 
LEC rats. Image file names are shown as they are designed in Bioplot software. The 
channel color was chosen according to test labeling.  
 
All samples were compared against the same control group.  
D.2.2.2 Quantitative RT-PCR of GSTP gene 
D.2.2.3 Proteasome peptidase activity determination in cytosol fractions 
D.2.2.4 Proteasome protein determination by western blotting 
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D.2.3 RESULTS  
D.2.3.1 Microarray analysis and validation 
The rat pangenomic microarray used in this study was made of 27004 oligo probes that 
corresponded to 22012 rat genes. After scanning, images were analyzed by the Bioplot 
software; Lowess-normalized data set with test/control (untreated/D-penicillamine 
treated rats) ratios were obtained. In order to evaluate the difference between test groups 
and the control group, means of ratio were calculated and after a student t-test, genes 
were considered as differential genes when they showed a P < 0.05. In Figure 12 the 
scatter plots of each comparison are shown. Each spot is represented as log10 of mean 
ratio ± Standard Deviation as a function of the total intensity (Cy3 + Cy5). So the points 
falling at the right corresponded to those genes with the higher expression in the 
samples (high levels of mRNA) while those spots falling in the left were genes which 
expression is more reduced. 1673 differential genes were found in Normal 6w/D-
penicillamine comparison, among them 880 genes were upregulated (log10 ratio > 0, red 
spots) and 783 were downregulated (log10 ratio < 0, green spots) (Figure 12A). The 
number of differential genes in the Normal 9w/D-penicillamine comparison was 
diminished (777 differential genes), furthermore, the ratios of these differential genes 
were small ratios, showing that the gene expression profiles in liver samples from 
Normal 9w and D-penicillamine groups are quite similar (Figure 12B). As rats became 
diseased, differences between test and control groups were stronger. 1702 differential 
genes were founded in Slight jaundice/D-penicillamine comparison, among which 982 
were upregulated and 720 downregulated. In the Jaundice/D-penicillamine comparison, 
1817 differential genes were founded, 1035 upregulated and 782 downregulated (Figure 
12C and D).  
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Figure 12. Ratio/Intensity scatter plots: In black: non-differential genes (P > 0.05); in 
red: differential upregulated genes (P < 0.05 and log10 ratio > 0). In green differential 
downregulated genes (P < 0.05 and log10 ratio < 0). A. Normal 6w vs D-penicillamine 
comparison. B. Normal 9w vs D-penicillamine comparison. C. Slight jaundice vs D-
penicillamine comparison. D. Jaundice vs D-penicillamine comparison. P values were 
calculated by student-t test. 
 
In order to describe in a global context the gene expression changes during hepatitis 
development, multivariate statistical analyses were performed. Normalized data sets 
were filtered by ANOVA test when considering the group factor. From 27004 oligo 
probes, 696 probes with a P value < 0.05 were considered as significant variables. 
Probes were then subjected to an orthogonal signal correction (OSC) filtering in order to 
remove strong structured variation in X matrix (transcriptomic data) that is not 
correlated to Y matrix (class group) (Trygg, 2002). 89.88% of the information remained 
after this correction. In order to discriminate between genes related to hepatitis 
progression and those mainly explained by a age effect, a PLS-2 regression between the 
696 statistically significant genes and plasma hepatitis markers ALT, AST and t-bil was 
performed (Figure 13A). The goal of this method is to analyze or predict a set of 
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dependent variables (matrix Y, i.e. plasma hepatitis markers) from a 
 
Figure 13. Relation between hepatitis progression and gene expression. (A) 696 
statistically significant variables from transcriptomic data (P < 0.05) were used for a 
PLS-2 regression against plasma hepatitis markers, ALT, AST and t-bil. (B) PLS-DA of 
transcriptomic data. Circles: rats within the same group. N6w: Normal 6w. N9w: 
Normal 9w. Sl-j: Slight jaundice. J: Jaundice. 
 
set of independent variables (matrix X, i.e. microarray data) or predictors (Abdi, 2003). 
PLS-2 regression showed a projection in which the Slight Jaundice and Jaundice groups 
were well separated from the non diseased groups, Normal 6w and Normal 9w. 
However, these two latter groups could not be separated between each other using this 
analysis.  The 696 genes were hence analyzed by a PLS-DA in order to refine the 
separation between all groups of rats (Figure 13B). PLS-DA is a supervised 
multidimensional statistical method that uses Principal Component Analysis (PCA) 
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principles, i.e. data projection into different dimensions, to find the components which 
account for differences between groups. As shown in Figure 13B, the projection on the 
first axis [t1] separated the non diseased rats (Normal 6w and Normal 9w groups) from 
diseased rats, and even more, this mode of analysis was able to improve the separation 
between groups of rats exhibiting a slight jaundice from those with a stronger disease. 
The separation between groups was validated using another discriminant analysis, the 
factorial discriminant analysis (FDA) (Figure 14), in which using only 10 variables 
selected from the first 696 ones by a specific algorithm (Dumas et al., 2002), ∆2 
Mahalanobis distances between all different groups were significantly different from 
zero (P < 0.001) (Table III). 
The oligo probes that contribute to axis building were defined using the Variable 
Importance Projection (VIP) criterion given by the SIMCA-P 8.0 software. Statistical 
VIP criterion is a measure which quantifies the influence on the response (on the latent 
variable describing the projection of hepatitis development) of each variable summed 
over all components and categorical responses relative to the total sum of squares of the 
model (Perez-Enciso et al., 2003). It is a useful tool to select specific sets of genes that 
distinguishes animals at different stages of hepatitis, making it an important parameter 
to find possible pathways involved in disease development. From the 696 tested genes, 
483 were considered as important for axis projection (VIP > 0.8) for the PLS-2 analysis 
and 239 for de PLS-DA. 50% of the 239 genes found to be important for the PLS-DA 
were also found to be important in the PLS-2 analysis, demonstrating that the separation 
of groups in the PLS-DA is mainly due to hepatitis development. Table A 
(supplementary data) provides the list of these 239 genes ordered by decreasing 
importance of the VIP value.  
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Figure 14. Factorial Discriminant Analysis (FDA) of transcriptomic data: 10 
variables from 692 significative variables (P < 0.05) were selected as important for axes 
building. The first axis (LD1) explains the 66.9% of the variance while the second axis 
explains the 19.3% of the variance.  
 
 
 
 
       
Table III. ∆
2
 Mahalanobis distances between all different groups represented in FDA 
test. The probability of these distances to be null is represented. 
 
 
GSTP was found among the list of genes that significantly discriminated groups. We 
confirmed the expression changes of this gene by the qRT-PCR method using β-actin as 
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the reference gene (F3,23 = 54.82, P = 0.0104) (Figure 15). Therefore, this data together 
with the fact that this gene is considered as a tumor marker known to be expressed in 
LEC rats during hepatitis (Masuda et al., 1989) consolidated the validity of our 
transcriptomic analysis of LEC rats during hepatitis development. 
  
            
Figure 15. Confirmation of the differential expression of GSTP by quantitative RT-
PCR. Triangles: GSTP expression units from microarray data. Open circles: GSTP 
expression units from TaqMan QRTPCR assay. Data is expressed as ratio Test/Control 
ratio (means ± SD) where control is D-penicillamine-treated rat group. Means without a 
common letter differ as determined by a one-way ANOVA and the Bonferroni post-hoc 
test. 
 
 
D.2.3.2 Functional classification of VIP genes  
To gain more biological insights of our expression data, the list of 239 genes with a 
significant VIP value (VIP > 0.8) were subjected to a functional classification based on 
Gene Ontology annotation (GO). Only 40% of the total rat genome has a gene ontology 
annotation (Lomax, 2005). This explained that only 59 genes had a GO annotation in 
Biological Process ontology from the 239 selected genes (Figure 16). From these GO
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Figure 16. Gene ontology classification for 59 known genes. Classification by 
biological process was made (1-10). Chart data are read as: Category name (Accession): 
number of tested genes annotated in this category, percent of tested genes annotated in 
this category against total tested genes having a GO annotation. 
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Figure 17. Metabolism ontology sub-classification. Genes being part of metabolism 
classification were sub-classified according to their specific activity (1-25). Chart data 
are read as: Category name (Accession): number of tested genes annotated in this 
category, percent of tested genes annotated in this category against total tested genes 
having a GO annotation. 
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TABLE IV. Differential genes classified in GO: Protein Metabolism 
Description Symbol Oligo_id ENSEMBLE Gene_id Genbank Ratio p value 
          Normal 
6w 
Normal 
9w 
Slight 
jaundice 
Jaundic
e 
  
Cathepsin D precursor (EC 
3.4.23.5) 
Cts. Rn30018601 ENSRNOG00000020206 NM_134334 1.14a 1.09a 1.86a,b 2.44b 0.0207 
Glycine N-methyltransferase (EC 
2.1.1.20)  
Gnmt Rn30014947 ENSRNOG00000016349 X06150 0.73a 0.85a,b 0.55b 0.41b 0.0050 
C-reactive protein precursor Crp R002545_01 ENSRNOG00000000053 DW387982 0.68a 0.89a,b 0.45b 0.35b 0.0344 
H-2 class II histocompatibility 
antigen, gamma chain  
Cd74 Rn30017236 ENSRNOG00000018735 CB576583 1.06a 1.15a 1.73b 2.36c 0.0125 
Meprin A alpha-subunit precursor 
(EC 3.4.24.18)  
Mep1a R004430_01 ENSRNOG00000011022 BC081834 0.97a 0.95a 0.61b 0.92a 0.0351 
proteasome 26S non-ATPase 
subunit 12 
Psmd12 Rn30002776 ENSRNOG00000003117 BC083758 1.10a,b 1.01a 1.05a,b 1.48b 0.0160 
Calpain small subunit 1 (CSS1)  Capns1 Rn30001369 ENSRNOG00000001503 BC098068 0.94a,b 0.98a 1.11a,b 1.39b 0.0408 
Serum amyloid P-component 
precursor (SAP) 
Apcs R000224_01 ENSRNOG00000009086 X55761 1.01a 0.84a,b 0.41b 0.54a,b 0.0071 
Complement C1q subcomponent 
subunit A precursor 
C1qa Rn30011801 ENSRNOG00000012807 BC086605 1.00a 0.95a 1.67a,b 1.91b 0.0439 
TGFB inducible early growth 
response 3 (predicted)  
Gna14 Rn30013625 ENSRNOG00000014840 BC090316 0.90a 0.96a 1.24b 0.94a 0.0465 
Kit ligand precursor (C-kit ligand)  Kilt R003524_01 ENSRNOG00000005386 NM_021843 1.09a 0.96a 0.90a 1.46b 0.0406 
Legumain precursor (EC 3.4.22.34)  Lgmn Rn30006415 ENSRNOG00000007089 BC087708 1.05a,b 0.93a,b 1.36a 1.57b 0.0169 
Ubiquitin-conjugating enzyme E2 
B (EC 6.3.2.19) 
UBC2_H
UMAN 
Rn30004545 ENSRNOG00000005064 AF144083 1.01a,b 0.99a,b 1.17a 1.52b 0.019 
Proteasome subunit beta type 8 
precursor (EC 3.4.25.1)  
Psmb8 R004525_01 ENSRNOG00000000456  
NM_080767 
1.11a 1.07a 1.16a 1.27b 0.0317 
Proteasome subunit alpha type 6 
(EC 3.4.25.1) 
Psma6 Rn30006440 ENSRNOG00000007114 NM_017283 1.10a 1.01a 1.16a,b 1.44b 0.0132 
Proteasome subunit beta type 5 
precursor (EC 3.4.25.1) 
Psmb5 Rn30012312 ENSRNOG00000013386 XM_341314 0.93a 1.05a 1.15a,b 1.43b 0.0213 
proteasome 26S, non-ATPase 
regulatory subunit 6 
 Psmd6 Rn30006048 ENSRNOG00000006751 BC059159 1.03a 1.03a 0.89a 1.60b 0.0306 
Aminopeptidase B (EC 3.4.11.6)  Rnpep R002043_01 ENSRNOG00000006720 AY724503 0.86a 0.95a 0.62b 1.11a 0.0465 
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TABLE V. Differential genes classified in GO: Nucleobase, Nucleoside, Nucleotide and Nucleic acid Metabolism 
 
 
Description Symbol Oligo_id ENSEMBLE Gene_id Genbank Ratio p value 
          Normal 
6w 
Normal 
9w 
Slight 
jaundice 
Jaundice   
Uricase (EC 1.7.3.3)  Uox Rn30014939 ENSRNOG00000016339  M24396 0.69a 1.04a,b 0.57b 0.50b 0.0234 
Growth arrest and DNA-damage-
inducible protein GADD45 alpha 
Gadd45a R001492_01 ENSRNOG00000005615  CO396252 1.00a 0.94a 1.06a,b 1.49b 0.0055 
Signal transducer and activator of 
transcription 3 
Sta3 Rn30018174 ENSRNOG00000019742  NM_012747 0.84a 0.86a 1.56b 1.72b 0.0498 
Dynamin-2 (EC 3.6.5.5) Dnm2 Rn30006927 ENSRNOG00000007649  L25605 1.03a 1.06a 1.03a 1.58b 0.0151 
Runt-related transcription factor 1, 
Acute myeloid leukemia 1 protein 
Runx1 Rn30001533 ENSRNOG00000001704  L35271 0.93a 1.05a 1.27b 1.23b 0.0280 
Cellular nucleic acid binding 
protein, Zinc finger protein 9 
Cnbp1 R000749_01 ENSRNOG00000010239  CB743905 1.06a,b 1.09a 1.07a,b 1.45a,b 0.0298 
DNA-repair protein XRCC1 Xrcc1 Rn30018333 ENSRNOG00000019915  AF290895 1.02a,b 0.98a 1.22a,b 1.54a,b 0.0338 
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annotated genes, 38 fall into Metabolism, 19 in Organismal Physiological Process and 
19 in Regulation of Physiological Process categories. A sub-classification in Cellular 
Metabolism category revealed that genes implicated in Protein Metabolism, and in 
Nucleobase, Nucleoside, Nucleotide and Nucleic acid Metabolism were overrepresented 
(Figure 17). Values of expression changes of these genes and their associated function 
are described in Tables IV and V. 
                                                                              
       
Figure 18. Proteasome structure: 26S proteasome is composed of two subcompexes; a 
20S core particule (CP) in which catalytic activity is present; and two 19S (PA700) 
particules in which recognition of ubiquitin and protein defolding take place.  
 
D.2.3.3 Proteasome activity 
 
The proteasome (Figure 18) is a large, 26S, multicatalytic protease that degrades 
polyubiquitinated proteins to small peptides. It is composed of two subcomplexes: a 20S 
core particle that carries the catalytic activity, and the regulatory 19S particle 
(Ciechanover, 2005). The main function of the proteasome is to degrade superfluous 
and/or damaged proteins by proteolysis. Our DNA microarray data revealed that several 
genes in the Protein Metabolism sub-category whose expression was increased in LEC 
rats during hepatitis are implicated in protein degradation by the proteasome (Table IV). 
Furthermore, a heat map of proteasome-related genes showed a tendency of 
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upregulation of almost all genes that encode the 19S and 20S proteasome in Jaundice 
group of rats (Figure 19). Among them, six genes were significantly increased. This 
result suggested that the proteasome activity could be modified. To verify this 
hypothesis, we determined the peptidase activities of 20S proteasome using specific 
fluorogenic peptides as substrates n cytosolic fractions (Figure 20). Unexpectedly, there 
was no significant modification of the chymotrypsin-like (ChT) proteasome activity
 
Figure 19. Heat map of proteasome-related genes in the liver of LEC rats at different 
disease stages.  Mean expression ratios of proteasome-related genes in each rat groups 
in respect to D-penicillamine-treated rats. Green and red represent downregulation and 
upregulation, respectively, as indicated in the “Ratio Scale” bar. (A) 20S proteasome-
related genes. (B) 19S proteasome-related genes. * P < 0.05. 
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(Figure 20A) even when the gene encoding the proteasome subunit responsible for this 
activity, the Pmsb5 gene, was significantly up-regulated (Table IV). Moreover, we 
found a significant decrease in trypsin-like (TL) proteasome activity in Slight jaundice 
and Jaundice groups of rats (F4, 25 = 58.62, P < 0.0001) (Figure 20B). Likewise, the 
peptidylglutamyl peptide hydrolase (PGPH) proteasome activity was diminished by 
about 30% in the Slight jaundice group (Figure 20C), but restored in the Jaundice rat 
group (F4, 25 = 13.01, P = 0.0075). Both genes responsible for TL (Psmb2 gene) and 
PGPH (Psmb1 gene) had a tendency of being overexpressed during hepatitis (Figure 
19A).  
In order to evaluate whether changes in proteasome activities were due to variations in 
proteasome protein levels, we evaluated the 20S proteasome levels in cytosol by 
Western blotting. As shown in Figure 21, 20S proteasome levels were increased by 1.5 
and 1.8 fold, respectively in Slight jaundice and Jaundice groups with respect to control 
D-penicillamine group (F4, 25 = 10.86, P = 0.015). Thus, a decrease in TL and PGPH 
proteasome activities does not correspond to a decrease in 20S proteasome levels but 
rather to an inhibition of the intrinsic protein activity. 
 
D.2.3.4 Effect of D-penicillamine on gene expression 
In order to define if the treatment with D-penicillamine changes gene expression, Long 
Evans (LE) rats were submitted to a treatment with D-penicillamine in the same way as 
D-penicillamine-treated LEC rats. Both groups, non treated LE rats (LE) and D-
penicillamine-treated LE rats (LE-D-penicillamine) were compared against D-
penicillamine-treated LEC rats. From the LE/D-penicillamine comparison 3213 genes 
were considered as differential genes (P < 0.05), 1799 were upregulated (log10 ratio > 0) 
and 1414 were downregulated (log10 ratio < 0) (Figure 22A). When 
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Figure 20. Changes in proteasome activities in the liver of LEC rats at different 
disease stages. The proteasome activities in the liver of LEC rats in different groups 
were measured using the fluoropeptides, s-LLVY-AMC for the ChL activity (A), Boc-
LSTR-AMC for the TL activity (B), and Z-LLE-βNA for the PGPH activity (C), as 
substrates. Each determination was performed at least in triplicate. Values refer to 
proteasome activity means ± SD. Means without a common letter differ as determined 
by a one-way ANOVA and the Bonferroni post-hoc test.   
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comparing LE rats treated with D-penicillamine against D-penicillamine LEC-rats only 
413 differential genes were found, these genes might correspond to strain differences 
(Figure 22B). Venn diagram allowed us to define those differential genes presumed to 
be altered by D-penicillamine treatment. 3130 genes were modulated by D-
penicillamine (Figure 22C). Genes in VIP selection of the PLS-DA that might be altered 
by D-penicillamine treatment are signaled in Table A (Annex 1). 
 
                 
Figure 21. Immunodetection of proteasome in liver of LEC rats at different disease 
stages and treatments. (A) Representative image of immunoblot analysis for 20S 
proteasome and alpha-tubulin proteins. (B) Densitometry analysis of immunoblot assay, 
values refer to proteasome/alpha-tubulin ratio means ± SD (n=6). Means without a 
common letter differ as determined by a one-way ANOVA and the Bonferroni post-hoc 
test. 
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Figure 22. Effect of D-penicillamine on gene expression patterns. A. Scatter plot of 
Long Evans/LEC D-penicillamine comparison. B. Scatter plot of D-penicillamine-
treated Long Evans/LEC D-penicillamine comparison. C. Venn diagram of both 
comparisons, 3130 genes were assumed to be deregulated due to D-penicillamine 
treatment in Long Evans rats. 
 
 
D.2.4 DISCUSSION 
A first evaluation of gene expression in LEC rats was made by Klein et al. in 2003 
(Klein et al., 2003). From their transcriptomic analysis, authors have only retained 
genes with the highest expression changes, and from these data, concluded on a major 
role of oxidative stress, inflammation and DNA damage in hepatitis progression. 
However, this mode of data analysis is too restrictive and there is no obvious 
relationship between the levels of gene expression and the intensity of the disease since 
alterations in a given cellular activity are usually not the result of a single but often 
depends on the coordinated effects of multiple genes (Valafar, 2002).  
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To optimize the exploration of large data sets such as transcriptomic data in a given 
biological context, multivariate statistical methods followed by Gene Ontology 
classification represent powerful tools of analysis. We considered D-penicillamine-
treated LEC rats as a suitable control group for transcriptomic analyses. We checked in 
LE rats the effect of D-penicillamine in gene expression. Even when there are some 
modifications in gene expression patterns due to D-penicillamine treatment, D-
penicillamine had no effect in the genes here discussed. 
PLS-2 analysis between microarray and plasma hepatitis markers showed a projection 
of group of animals regarding hepatitis, which means a strong correlation between gene 
expression changes and the development of hepatitis in LEC rats. This method was 
effective to separate between non-diseased groups from jaundice groups, but it was not 
pertinent enough to discriminate the two non-diseased groups (Normal 6w and Normal 
9w), probably because the number of hepatitis markers is much reduced and their values 
are very similar between these groups. PLS-DA takes the advantage of prior class 
information to attempt to maximize the separation between groups of observations 
(Perez-Enciso et al., 2003). All groups were significantly separated from each other by 
PLS-DA. Furthermore, more than 50% of VIP-positive genes from PLS-DA were 
common to those coming from PLS-2 regression demonstrating that PLS-DA group 
separation is also well correlated to animal hepatitis development. 
Statistical VIP criterion serves as a powerful tool to select the variables that have a 
strong impact on the building of the axes in PLS methods. A high VIP value implies a 
strong influence of the variable in the axes building (Perez-Enciso et al., 2003). GSTP 
presented one of the highest VIP value (VIP value = 3.902), suggesting that the increase 
in expression of this gene was very important for separation between groups of rats in 
the PLS-DA. This finding agrees with the fact that we had found GSTP in liver of LEC 
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rats during hepatitis. Furthermore, since GSTP is considered as one of the most reliable 
tumor markers in liver (Sawaki et al., 1990), the idea of cancer initiation during 
hepatitis in LEC rats is enforced. 
During hepatitis progression in LEC rats, a strong oxidative stress takes place 
(Yamamoto et al., 2001). Oxidation of biomolecules as DNA, lipids and proteins has 
been extensively described (Yamamoto et al., 2001; Nair et al., 2005; Yasuda et al., 
2006). According to these observations, our analyses of microarray data show 
enrichment of genes that belong to Protein Metabolism and Nucleobase, Nucleoside, 
Nucleotide and Nucleic acid metabolism established by GO classification. Genes 
involved in Nucleobase, Nucleoside, Nucleotide and Nucleic acid metabolism, and 
genes involved in DNA reparation are up-regulated in Jaundice group. Growth Arrest 
and DNA Damage 45-alpha (GADD45-alpha) is a nuclear protein involved in the 
maintenance of genomic stability, DNA repair, and suppression of cell growth. 
Overexpression of GADD45 gene has been reported in LEC rats at early stages of 
hepatitis suggesting important DNA damage (Klein et al., 2003). The mechanisms by 
which oxidized DNA bases are repaired include the base excision repair (BER) 
pathway. M1G, etheno-DNA adducts, 8-hydroxyguanine and other oxidized base 
lesions are removed by this pathway (Valko et al., 2006). Acute hepatitis in LEC rats 
impairs the repair of oxidative DNA base damage by altering the activity of DNA 
glycosylases, endonuclease II and 8-oxoguanine DNA-glycosylase, which initiate the 
BER pathway (Choudhury et al., 2003). Interestingly, our results show overexpression 
of DNA-repair protein XRCC1 gene. XRCC1 protein seems to play a central role in 
coordinating the enzymes participating in BER pathway (Marsin et al., 2003). 
Moreover, XRCC1 protein interacts with all enzymes of BER downstream of DNA-
glycosylase leading to the stabilization of the corresponding enzyme. Hence, up-
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regulation of XRCC1 in LEC diseased groups may contribute to BER pathway recovery 
in LEC rats. Further investigations are needed to determine the role of XRCC1 in BER 
pathway in LEC rats.  
Protein Metabolism was the one category with the highest amount of associated genes. 
The results may indicate an increase in protein degradation, since genes falling in this 
category are genes related to ubiquitin-proteasome system and to other peptidases. 
Increase in protein degradation could reflect protein damage as protein oxidation (Grune 
et al., 1995). According to our results showing overexpression of genes involved in both 
19S and 20S proteasome system, our initial hypothesis was that proteasome activity 
should be augmented in Slight jaundice and Jaundice groups. However, TL and PGPH 
20S proteasome peptidase activities were diminished in these groups. Protein levels of 
proteasome were significantly increased in Slight jaundice and Jaundice groups 
compared to D-penicillamine group, suggesting that the diminution of proteasome 
activities may not be due to less proteasome proteins in cell, but rather because of a 
direct inhibition of protein activity.  
If oxidized proteins are not eliminated through proteasome pathway, they are able to 
accumulate and to aggregate (Grune et al., 2003b). Oxidized protein aggregates are very 
difficult to eliminate because they can not be unfolded, an important step in protein 
degradation, and they are able to cross-link with proteasome subunits enhancing 
proteasome inhibition. HNE, a major end product of lipid peroxidation, modifies 
proteins leading to the formation of such protein aggregates (Grune et al., 2003a). 
Furthermore, HNE can inhibit directly the proteasome activity by covalent binding to 
proteasome subunits. Okada et al. (1999) have found similar results for the inhibition of 
TL and PGPH peptidase activities under oxidative stress conditions in kidney. Authors 
concluded that HNE-proteasome adduction was partially responsible for the proteasome 
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inhibition under oxidative stress conditions (Okada et al., 1999). Although the detailed 
mechanism of inactivation of proteasome with HNE is not fully understood, authors 
suggest that the active site of the enzymes (TL and PGPH) may preferentially react with 
HNE, leading inactivation. These findings lead us to propose, for the first time, the 
inhibition of proteasome activities by oxidative stress during hepatitis progression in 
LEC rats.  
Inhibition of proteasome activities may induce the expression of proteasome genes in a 
feedback mechanism that would compensate for the reduced protein degradation level. 
Feedback regulation of proteasome genes have been described in Saccharomyces 
cerevisiae.  Proteasome gene expression was mediated by Rpn4 protein, which binds to 
PACE (Proteasome associated control element) sequences that are found in the 
promoters of proteasome subunits (London et al., 2004). Rpn4 protein is actually 
degraded by the proteasome system, stabilization of Rpn4 by proteasome inhibition or 
malfunction leads increased transcription of proteasome subunits by a negative feedback 
circuit (Xie et al., 2001). In mammal cells, Meiners et al. (Meiners et al., 2003), have 
studied the expression of proteasome genes after the inhibition of ChT proteasome 
peptidase activity by specific proteasome inhibitors. They showed that there is a 
concerted change in the expression of almost all the 20S proteasome subunits following 
proteasome activity inhibition. Our results agreed with Meiners observations since even 
when not all the genes were statistically significantly overexpressed, there was a clear 
tendency for an upregulation of the majority of genes encoding for proteasome (Figure 
5). The implication of a common transcription factor like Rpn4 in transcriptional 
regulation of proteasome genes in mammal cells remains to be elucidated. 
The proteasome is an essential organelle that participates in different cellular functions, 
like apoptosis, survival and DNA reparation (Reed et al., 2007). Alterations in 
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proteasome activity have been related to metabolic perturbations, aging and different 
pathologies including Parkinson and Alzheimer diseases (Hayashi et al., 1998; 
Ciechanover, 2005; Reed et al., 2007). Oxidized and damaged protein accumulation 
may alter cellular functions, giving rise to deleterious effects on cellular homeostasis 
that could be involved in initiation and progression of carcinogenesis (Friguet, 2006; 
Cecarini et al., 2007). Interestingly, proteasome inhibition, either by specific inhibitor or 
by iRNA, induces the expression of GSTP gene in epithelial liver cells. Mechanisms of 
GSTP induction by proteasome inhibition seem to be different to Nrf2/Keap1 pathway 
(Usami et al., 2005). Further studies are necessary to know if there is an association 
between proteasome inhibition and GSTP upregulation in LEC rats, however the idea of 
proteasome inhibition in cancer initiation is proposed. 
In conclusion, using the LEC rat model, our work presents for the first time a genome-
scale analysis of hepatitis development and cellular responses due to copper-induced 
oxidative stress. In this study, multivariate statistical analysis coupled to a biological 
interpretation achieved by GO classification of the transcriptomic data allowed us to 
focus on proteasome system and on the consequences of proteasome inhibition as a 
main deregulated pathway that might be a determining factor during oxidative stress-
induced hepatitis and further cancer initiation. Our work shows an original and 
functional way of analysis that illustrates the power of multivariate statistical tools to 
explore microarray data to raise rational biological hypothesis. 
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D.3.1 INTRODUCTION AND AIMS 
 
Transcriptomic approaches are very useful to make a first exploration of understanding 
gene function and pathology. To fully use the information generated by these analyses, 
it is necessary to have a description of the changing phenotype so that gene expression 
can be further understood in a biological context. In this regard, metabonomics 
approaches provide a final link between gene expression and cellular phenotype 
(Nicholson et al., 2002).  
In LEC rats, metabolic perturbations that may predispose this rat strain to hepatitis and 
hepatocarcinogenesis have been described. Depleted liver selenium and deficiency in 
the activity of selenium dependent enzymes have been found (Downey et al., 1998). 
Lipid metabolism is also deregulated in LEC rats, as an increased content of 
triglycerides, free cholesterol and a reduction of bile acid export has been described in 
12 weeks old LEC rats (Levy et al., 2007).  Other perturbations have been explained as 
consequences of oxidative environment in LEC rat liver. Diminution of protein-thiols 
and of reduced glutathione, together with oxidative modification of glycoprotein’s 
oligosaccharides during hepatitis are some examples (Samuele et al., 2005; Yasuda et 
al., 2006). 
Whether metabolic perturbations in LEC rats are associated with gene expression 
changes during hepatitis and hepatocarcinogenesis development is difficult to explore 
by analyzing case by case. Our aims in this part of the work were first, to determine 
whether metabolic profiles obtained by 1H NMR could explain hepatitis development in 
LEC rats; and second, to define canonical correlations between transcriptomic data and 
final metabolic changes.  
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D.3.2 EXPERIMENTAL PROTOCOL 
 D.3.2.1 Sample preparation for 1H NMR analysis: Urine and liver extracts were 
prepared for 1H RMN analysis as described in the material and methods chapter. 
 D.3.2.2 Data analyses: 1H NMR spectra from 0.5 to 10 ppm were obtained and 
cut in 0.04 ppm buckets. Quantitative variables were generated by integrating the area 
under the curve of each bucket. From each 10 ppm spectra 220 variables were obtained. 
Variables were then subjected to multivariate statistical methods. OSC was performed 
to each group of data. Discriminant analyses (FDA and PLS-DA) were made in order to 
evaluate the discrimination between metabolic profiles belonging to each LEC rat 
group. PLS-2 regression between metabonomic data and hepatitis markers in plasma 
was performed in order to associate metabolic changes to hepatitis development. Finally 
a PLS-2 regression between liver metabolic and transcriptomic data was made with the 
objective of explaining metabolic changes by changes in gene expression patterns in the 
onset in LEC rats hepatitis.  
 
D.3.3 RESULTS 
 
D.3.3.1  
1
H NMR of urinary samples of LEC rats before and in the onset of hepatitis  
Urine samples collected from non-treated and D-penicillamine-treated LEC rats were 
analyzed by 1H NMR. Metabolic profiles were then analyzed and subjected to a 
factorial discriminant analysis (FDA) (Figure 23). The first factorial axis given by this 
analysis explained 41.9% of the variance and projection on this axis separates non-
treated from treated animals. The second axis explained 22.7% of the variance and 
projection on this axis pointed out at the same time the development of hepatitis for the 
non-treated animals and the metabolic changes due to the age of the animals. 
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Figure 23. FDA of 1H NMR spectra of urine samples: Urine samples from rats 
housed in metabolic cages were analyzed from 6 weeks old until sacrifice. 50 
discriminant variables were selected with a P < 0.05. Black arrow shows the trajectory 
from untreated animals towards hepatitis. Grey arrow shows the trajectory of D-
penicillamine-treated rats.  
 
 
The fact that we were able to discriminate rats that had received D-penicillamine from 
those rats without treatment lead us to ask if these differences would be related to 
difference in hepatitis development among the groups or to metabolic changes due to 
the age of the animals. In order to resolve this question a PLS-2 regression between 
urine 1H NMR metabolic profiles and plasma levels of hepatitis markers (ALT, AST 
and t-bil) was made. In figure 24, the relation between changes in metabolic profiles and 
plasma levels of hepatitis markers is shown. There was a good separation between rats 
treated with D-penicillamine and non-treated rats. The first component explained the 
45.1% of the variance from metabonomic data while the second component explained 
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Figure 24. PLS-2 regression between 
1
H NMR metabolic profiles (t[1] axis) and 
plasma levels of hepatitis markers (u[1]) axis 
 
 
 
 
Table VI. Identified metabolites that were related to hepatitis development in LEC 
rats: Variables were selected by a PLS-2 regression between metabonomics in urine 
and levels of hepatitis markers in plasma. cor: correlation coeficient 
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85.4% of the variance from biochemical data. These results mean that the differences in 
metabolic profiles in urine samples were related to disease development. 21 variables 
with a correlation coefficient (cor) above 0.8 between metabonomic and biochemical 
data were found. From these variables, only 4 were identified from 1H MNR spectra. 
Taurine, acetamide, and isoleucine were positively correlated with biochemical 
parameters, that means that when ALT, AST and t-bil plasma level augmented these 
variables also augmented, while citrate was negatively correlated to hepatitis markers 
(Table VI).  
 
D.3.3.2 Metabolic changes in liver of LEC rats at different hepatitis stages 
Since one of the main objectives of this work was to define a relation between 
transcriptomic and metabonomic data, we analyzed the changes in metabolome directly 
in liver samples of LEC rats at different hepatitis stages. Aqueous and lipophilic 
extracts of liver were obtained and analyzed by 1H NMR.  
In order to achieve a better correspondence between data from metabonomic and 
transcriptomic analysis, metabonomic data were expressed as the test/control ratio 
similarly to transcriptomic data. Test rats corresponded to non-treated LEC rats (classed 
according to hepatitis stages) and control rats corresponded to D-penicillamine-treated 
LEC rats. Ratios were obtained by comparing animals identically as done in microarray 
slides (See Table II). 
 
D.3.3.2.1 Metabonomic analysis of lipophilic extracts of LEC rat liver samples  
Figure 25 shows the pattern recognition analyses of metabonomic data from lipophilic 
(chloroform:methanol, 2/1,v/v) extracts of LEC rat liver samples at different hepatitis 
stages. Data were subjected to an OSC after which 51.4% of the information remained. 
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Figure 25. Pattern recognition analysis of 
1
H NMR spectra of lipophilic extracts from 
liver samples of LEC rats at different hepatitis stages:  A. PLS-DA. B. FDA of 10 
discriminant variables selected by ANOVA with a P < 0.05.  N 6w: Normal 6w; N 9w: 
Normal 9w; Sl j: Slight jaundice; J: Jaundice.   
 
 
            
 
 
Table VII. Mahalanobis distances between groups from FDA analysis of 
1
H NMR 
spectra of liver lipophilic extracts. 
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Discriminant analysis of the data showed the trajectory of groups from non diseased 
(Normal 6w and Normal 9w groups) to hepatitis (Slight jaundice and Jaundice groups). 
However, discrimination of groups was not so evident in the PLS-DA (Figure 25A). 
AFD with 10 discriminant variables was better to oppose non-diseased rats from 
diseased rats in the first axis which explained the 79.9% of the variance between groups. 
The probability of Mahalanobis distance to be null were very low (P < 0.001) (Table 
VII).  
D.3.3.2.2 Metabonomic analysis of aqueous extracts of LEC liver samples  
Aqueous (acetonitrile:H2O, 50/50, v/v) liver extracts were subjected to high resolution 
1H RMN and changes in metabolic profiles were then analyzed by pattern recognition 
analyses (Figure 26). 60.1% of information remained after an OSC. Both discriminant 
analyses (PLS-DA and FDA) showed a good separation of each group of LEC rats with 
a trajectory that explained hepatitis development in the first axis. Furthermore, FDA 
analysis using 10 discriminant variables explained the 81.7% of the variance between 
groups in the first axis. The probability of Mahalanobis distance to be null were very 
low (P < 0.001) (Table VIII). Variables that explained the axes building are shown in  
Table IX. 
Interestingly, the trajectory in which hepatitis development was explained by 
metabonomic data of aqueous liver extracts was very similar of that seen by 
transcriptomic data (Figure 14). So we focused on these data coming from aqueous 
extracts to explore if there was any relation between metabolic profile changes and gene 
expression changes due to hepatitis development. 
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Figure 26.  Pattern recognition analyses of 
1
H NMR of aqueous liver extracts of LEC 
rats at different hepatitis stages: A. PLS-DA. B. FDA from 10 discriminant variables 
selected by ANOVA with a P < 0.05. N 6w: Normal 6w; N 9w: Normal 9w; Sl-j: Slight 
jaundice; J: Jaundice. Arrows indicate the trajectory on the axes from non-diseased to 
diseased rat groups. 
 
       
 
Table VIII. Mahalanobis distances between groups from FDA analysis of 
1
H NMR 
spectra of liver aqueous extracts 
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Table IX. Discriminant variables selected by ANOVA (P  < 0.05) in a FDA: Metabolite associated gene ontology descriptions are shown. 
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D.3.3.3 Quantitative relationship between metabonomic and transcriptomic analyses 
In order to define whether gene expression changes could explain the changes in 
metabolic profiles seen in aqueous extracts of liver samples of LEC rats, a PLS-2 
regression between transcriptomic data (as X matrix) and metabonomic data (as Y 
matrix) was done (Figure 27A). The correlation between both data showed a linear 
trajectory that explained hepatitis development. The first component for transcriptomic 
data explained the 34.3% of the variance, while the first component for metabonomic 
data explained the 30.6% of the variance between groups.  
In order to know which variables were correlated between the two omics analyses, a 
correlation matrix between both groups of data was done. From it, 39 variables with a 
correlation coefficient above 0.85 were selected (Table B, annexes). The representation 
of transcriptomic and metabonomic variables in a Cartesian plane showed positive and 
negative correlation between variables (Figure 27B). This kind of analysis allowed us to 
demonstrate that it was possible to associate changes in metabolic profiles (Y) due to 
hepatitis development by changes in gene expression patterns (X). D.3.4  
 
DISCUSSION 
 
Metabolic perturbations related to copper accumulation and oxidative stress have been 
extensively described. Copper induces ROS formation which in turns inhibit 
mitochondrial enzymes like α-ketoglutarate dehydrogenase and pyruvate dehydrogenase 
(Sheline et al., 2004). Deregulation in lipid metabolism was observed in a mouse model 
of Wilson’s disease, in which the main modification was an inhibition of cholesterol 
metabolism (Huster et al., 2007). Moreover, the production and metabolism of ROS is 
highly regulated by metabolic pathways, the pentose phosphate cycle acting
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Figure 27 . PLS-2 regression between transcriptomic and metabonomic data. A. PLS-
2, transcriptomic data (X matrix) was used to explain metabolic changes (Y matrix) in 
aqueous extracts of LEC rat livers at different hepatitis stages. B. Correlation between 
variables from transcriptomic data (green circles) and metabonomic data (orange 
boxes). Variables with a correlation coefficient > 0.85 are represented. N 6w: Normal 
6w; N 9w: Normal 9w; Sl-j; Slight jaundice; J: Jaundice.  
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actually as the main metabolic response under oxidative stress with the production of 
NADPH, a metabolite indispensable to maintain cellular reductive capacity (Tuttle et 
al., 2007). Because alterations in physiological status by oxidative stress can break 
homeostasis, resulting in ultimate changes in metabolites, metabonomic analyses are of 
interest in studying and understanding the molecular mechanism of diseases.  
Using 1H NMR coupled with pattern recognition techniques, we were able to 
discriminate LEC rats undergoing hepatitis in both urine and liver samples. 
Metabonomic analysis of urine samples showed that differences between untreated and 
D-penicillamine treated LEC rats were related to hepatitis development as seen by its 
good correlation with hepatitis markers in plasma. Furthermore, from the identified 
urine metabolites (Table VI), taurine and acetamide groups were positively correlated 
with plasmatic markers. Interestingly, taurine has been reported to be depleted in the 
liver under oxidative stress due to chronic alcohol administration to rats (Kerai et al., 
2001), while hypertaurinuria has been observed when hepatotoxins were administered 
to rats (Sanins et al., 1990). In our study on liver metabonomic data, taurine variable 
was not selected. The acetamide group might be directly related to oxidative 
degradation of bilirubin, as oxidative metabolites of bilirubin bearing an acetamide 
function have been evidenced under oxidative stress conditions such as subarachnoid 
hemorrhage (Kranc et al., 2000). The fact that pattern recognition techniques 
discriminates diseased animals from non diseased in urine samples is promising while 
new markers of hepatitis could be further identified and used as non-invasive tests.  
Analysis of liver samples revealed that in both lipophilic and aqueous liver extracts, 
metabolic changes are associated with hepatitis development as seen by a trajectory 
from non diseased LEC rats (Normal 6w and Normal 9w groups) towards diseased LEC 
rats (Slight jaundice and Jaundice groups). However, in this work, we focused on 
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aqueous extracts to understand metabolic perturbations regarding hepatitis and 
transcriptomic data because of similar trajectories we obtained between metabonomic 
and transcriptomic data (Figure 14 and 26). However further studies should be done in 
order to identify and to explore changes in non polar metabolites.  
Aqueous metabolites that were of importance for axis construction in FDA showed that 
metabolic perturbations associated with hepatitis development included energetic 
metabolism and amino acid metabolism (Table IX). Decreased levels of α-glucose lead 
to the hypothesis of accelerated glycolysis. Perturbation of amino acid metabolism was 
evident with increased levels of lysine and glutamate in Slight jaundice and Jaundice 
groups. Enhanced glycolysis has been proposed as a protection mechanism face to 
oxidative stress in cancer cells (Kondoh et al., 2007). In proliferating cells, transitional 
augmentation of aerobic glycolysis and reduced ROS formation have been explained by 
two cooperative effects: (a) generation of antioxidant molecules like pyruvate, citrate 
and glutamate, and (b) prevention of excessive ROS production by keeping the rate of 
mitochondrial glucose oxidation at basal levels (Brand, 1997; Wu et al., 2004). The 
hypothesis of glucose enhanced metabolism as an adaptive response to oxidative stress 
in LEC rat hepatitis is questioned and more studies should be made to test this idea. 
Increase in lysine and glutamate could reflect the increase in protein catabolism 
occurring during hepatitis.  
Integrative biology refers to the integration of biological data to elucidate the cellular 
network as a whole (Joyce et al., 2006). Integration of omics data is not easy to achieve 
and requires the use of dedicated statistics and bioinformatics tools. Here we used PLS-
2 regression in order to correlate the metabolic changes in liver of rats suffering of 
hepatitis by changes in gene expression patterns. Very interestingly, we found a linear 
correlation between metabonomic and transcriptomic data associated with hepatitis 
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development and progression in LEC rats. This result might mean that both gene 
expression changes and metabolic perturbations are closely related face to hepatitis 
development. The correlation matrix formed by this analysis allowed us not only to 
select new genes that were modulated by oxidative stress-induced hepatitis and that 
were not evident in a single transcriptomic analysis, but also to formulate new 
hypothesis about cellular adaptation to oxidative stress. 
In a general context, the metabolites found to be correlated to gene expression changes 
were mainly related to oxidative stress and to cellular adaptation to it. Increased levels 
of oxidized glutathione, and amino acids related to glutathione biosynthesis (glutamate 
and glutamine) reflect the oxidative conditions under hepatitis. While, as mentioned 
above, diminution of glucose might reflect cellular protection to oxidative stress.  
Genes related to these conditions might reflect the cellular responses or consequences 
on general metabolic perturbations and not necessarily to a direct metabolite/gene 
relation. Diminution of cytochrome P450 gene expression, as it is the case in our study 
with the progression of hepatitis (Table B, annexes), has been described under oxidative 
stress and inflammation. Since basal activity of cytochromes P450 leads to a continuous 
ROS production, downregulation of cytochrome P450 genes has been considered as a 
mechanisms to protect cells of deleterious effects of ROS (Morgan, 2001). Mig-6 gene, 
which expression is also decreased with the progression of hepatitis (Table B, annexes), 
is coding for an adapter protein that has been associated with proliferation and 
differentiation control and is defined as an endogenous inhibitor of epidermal grow 
factor receptor (EGFR) signaling (Xu et al., 2005). Down-regulation of this gene might 
be associated with liver regeneration via hepatocyte proliferation as compensative 
response to acute hepatitis. Alpha-methylacyl-CoA racemase gene, which is down 
regulated with hepatitis in our study (Table B, annexes), is involved in the catabolism of 
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branched-chain fatty acids. Deficiency in this gene leads to decrease of bile acid 
synthesis and consequently to choleostasis (Setchell et al., 2003). 
The understanding of complex process like hepatitis and hepatocarcinogenesis is a big 
deal in which several processes should be examined at the same time: apoptosis, 
necrosis due to toxic effects of free radicals and in the other hand, inflammation and 
hepatocyte proliferation as compensative mechanisms of liver damage. Metabolic 
perturbations related to these events are not easy to elucidate, and the analysis of great 
amounts of information is required. Thanks to 1H NMR metabonomic analyses we were 
able to select, with a systemic approach, some metabolites that are related to oxidative 
stress-induced hepatitis. However, low sensitivity and difficulties in peak interpretation 
and molecule identification made the analysis restrictive to some identified metabolites 
present in huge amounts. Nevertheless, we can not discard the importance of 
metabonomic data, mainly as an integrated approach to transcriptomic data in 
formulating new questions about mechanisms that lead to hepatitis development and the 
association of hepatitis to cancer initiation. 
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The main objective of this work was to explore in a global scale the changes of gene 
expression and their relation with perturbations in metabolic profiles in a model of 
oxidative stress-induced hepatitis. Since acute hepatitis is closely related to liver cancer 
initiation in LEC rats, perturbations in gene expression and in metabolic profiles could 
also be analyzed within the scope of early modifications that can be associated with 
carcinogenesis.  
Transcriptomic approach led us to the construction of a database with the expression 
levels of 27004 oligo probes which correspond to almost all the rat genome. This 
database was used for the study of gene expression pattern and for the formulation of 
new hypotheses. One of the problems that we were confronted to was the biological 
interpretation of data, since only around 40% of genome has a defined function and 
hence our analysis was restricted to this. However, using our transcriptomic database 
and as advances in gene function definition arise, further analyses could be made in 
order to find new insights about mechanisms of hepatitis and hepatocarcinogenesis. 
Proteasome activity inhibition in LEC rats during hepatitis was a major finding; this is 
the first report that implicates proteasome inhibition during hepatitis and its possible 
consequence in hepatocarcinogenesis. We were able to achieve this finding thanks to 
the original analysis of data that we performed. Two points should be underlined from 
this finding: 1) Data analysis: data coming from transcriptomic analyses were 
performed without any restriction of pre-made hypotheses or bias that could arise from 
the exploration of a gene by gene analysis, where the observation of data is restricted to 
modifications in “expected” or “known” genes. And 2) validation of hypothesis raised 
from transcriptomic data is indispensable, not only by measuring the mRNA levels by 
other techniques but by testing the activity of the proteins coded by the selected genes. 
As it was the case for proteasome genes, where our initial hypothesis was an 
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upregulation in protein degradation because we found genes related to ubiquitin-
proteasome system upregulated, contradictory results could arise. 
Protein degradation by proteasome is a key mechanism in protein turnover. Proteasome 
activity deregulation may result in damaged proteins accumulation leading to toxic 
insults to cells and to modifications in signal pathways. It could be therefore interesting 
to evaluate the accumulation of oxidized proteins during the onset of hepatitis and to 
find a correlation between this damaged protein accumulation and cell perturbations that 
could results in cell cancer initiation. Oxidative stress-related modifications in 
proteasome activity have been described in vivo in a model of kidney carcinogenesis. 
Lipid peroxidation products such as HNE are directly implicated for proteasome activity 
inhibition. As HNE has been described as a key molecule for oxidative stress-related 
regulation of cell faith, it is also of interest to study the implication of HNE in ROS-
related inhibition of proteasome in liver. This would add more insights in the 
mechanisms of ROS induced carcinogenesis. 
In this work we were also interested in defining the changes in metabolic profiles that 
lead to hepatitis. Our analysis of the metabolome based on NMR-metabonomics showed 
a good correlation between changes in metabolic profiles and the levels of hepatitis 
markers in plasma that lead us to conclude that there should be a metabolic response 
face to oxidative stress and inflammation. However, the biological interpretation of 
metabonomic analyses was limited because of the sensitivity of the analytical method 
used to define metabolic profiles, the 1H NMR, and because of limitations in variable 
identification. Even when pattern recognition analyses showed a very good 
discrimination between groups with a trajectory that defined hepatitis development, the 
variable identification led to the definition of only some metabolites. Moreover, 1H 
NMR allows only the analysis of compounds that are present in huge amounts. We can 
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not discourage the use of 1H NMR for metabonomic analyses because it gives a 
complete overview of well represented metabolites, but complementary analytical 
procedures might be done, as mass spectrometry, in order to define some other 
metabolites that are not concentrated enough to be seen  by NMR.  
Systems biology is a new discipline in biology that aims to integrate omic data between 
each other and with other biological observations. Here, in an effort to better understand 
the mechanism that lead to a hepatitis phenotype, we integrated the data coming from 
transcriptomic techniques with those data coming from 1H NRM metabonomic analyses 
in liver samples. PLS-2 regression between these two different data sets showed a linear 
correlation between transcriptomic and metabonomic data in explaining the hepatitis 
development. This result is very important since it would mean that both changes in 
gene expression patterns and in metabolic profiles were closely correlated.  
It was exiting to find correlation between transcriptomic and metabonomic data because 
this may allow to new biological signatures implicated in ROS-induced liver diseases. 
Furthermore, this is a significant advance in the discovering of new insights on 
mechanism of hepatitis and in the discovering of possible early markers of 
hepatocarcinogenesis. However, there was no evident biological relation between both 
data (mRNA levels and metabolic profiles). It is worth to say that these kind of 
canonical analyses allow us to explore the relationship between to set of variables, but it 
does not mean a direct relation gene: metabolite. From our analysis, only one direct 
relationship between gene and metabolite has been detected where aldehyde 
dehydrogenase 18 is involved in glutamine degradation (Table B). However, some 
hypotheses can be made and further investigated, for instance concerning the role of 
cytochromes P450 in the development of hepatitis.  
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The expression levels of the genes that are directly related to the metabolites selected by 
the PLS2 (genes which code for enzymes involved in their metabolic pathways) were 
not significantly modified. Hence, there were not selected by the multivariate statistical 
analyses. The fact that there were metabolic perturbations that explain the progression 
of hepatitis, but that these perturbations could not be biologically explained by changes 
in gene expression patterns lead us to suppose that there should be modification in the 
enzyme levels or activity. Therefore it should be important to analyze the changes in 
protein profiles that would be related to hepatitis development. Proteomics could be 
used then as a complementary tool in order to gain complete information of cellular 
response face to oxidative stress and inflammation. Using the whole data coming from 
these three principal omic approaches (transcriptomics, proteomics and metabonomics), 
we would be able to integrate the puzzle of the relationship gene: protein  protein: 
metabolite that may explain complex processes like hepatitis and cancer initiation.   
Furthermore, using proteomic analyses it would be not only possible to evaluate directly 
the accumulation of oxidized proteins caused by perturbations in proteasome activity 
but also to identify possible targets of ROS-induced protein modifications implicated in 
hepatitis and cancer initiation processes. 
Finally and as a general comment of this work I want to say that omic analyses are 
nowadays very popular in biological and pharmaceutical research, their applications in 
clinical and pharmacological investigations are promising, since we will be able to 
study in a global scale the physiological or pathological cellular responses face to 
diseases or to drug exposition, new insights in mechanism of diseases would be 
elucidated, new biological markers of disease or toxicological effect would be found. 
This new vision in biology implies the management and the interpretation of high 
amount of data, and the integration of disciplines of different fields such as chemistry, 
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biology, physiology, informatics, mathematics is indispensable in the objective of 
diminishing the reductionism vision of individual component study for explain complex 
phenomena or to avoid the bias of “what we want to find” that could arise from pre-
made hypothesis. 
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